KR20110131783A - Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity - Google Patents

Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity Download PDF

Info

Publication number
KR20110131783A
KR20110131783A KR1020100051405A KR20100051405A KR20110131783A KR 20110131783 A KR20110131783 A KR 20110131783A KR 1020100051405 A KR1020100051405 A KR 1020100051405A KR 20100051405 A KR20100051405 A KR 20100051405A KR 20110131783 A KR20110131783 A KR 20110131783A
Authority
KR
South Korea
Prior art keywords
panax
ginseng
extract
cosmetic composition
acid
Prior art date
Application number
KR1020100051405A
Other languages
Korean (ko)
Inventor
김복득
이주엽
송규춘
박서영
황종현
Original Assignee
주식회사 진생사이언스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 진생사이언스 filed Critical 주식회사 진생사이언스
Priority to KR1020100051405A priority Critical patent/KR20110131783A/en
Publication of KR20110131783A publication Critical patent/KR20110131783A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Abstract

PURPOSE: A composition containing processed extract of Panax plants is provided to protect keratinocytes irritated by UV and to ensure anti-aging. CONSTITUTION: A cosmetic composition for anti-aging contains processed Panax ginseng extract as an active ingredient containing more ginsenoside Rg3, Rg5, and Rk1 content than ginsenoside Rb1, Rb2, Rc, and Rd content. The processed Panax ginseng extract is prepared by slicing the Panax ginsengs and heating the Panax ginsengs in an autoclave at 70°C-150°C for one hour to 24 hours. The Panax ginsengs are Panax ginseng C.A. Meyer, Panax quinquefolium, Panax notoginseng, Panax japonicum, Panax trifolium, or Panax pseudoginseng.

Description

가공인삼 추출물을 유효성분으로 함유하는 피부 노화 방지용 화장료 조성물 {Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity}Cosmetic composition for anti-aging containing ginseng extract as an active ingredient {Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity}

본 발명은 가공인삼 추출물을 유효성분으로 포함하는 피부 노화 방지용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for preventing skin aging comprising a processed ginseng extract as an active ingredient.

[문헌 1] Fisher, G.J., Wang, Z.Q., Datta, S., Varani, J., Kang, S., Voorhees, J.J., . Pathophysiology of premature skin aging induced by ultraviolet light. N. Engl . J. med . 337, pp.1419-1428, 1997.Reference 1 Fisher, GJ, Wang, ZQ, Datta, S., Varani, J., Kang, S., Voorhees, JJ,. Pathophysiology of premature skin aging induced by ultraviolet light. N. Engl . J. med . 337 , pp. 1419-1428, 1997.

[문헌 2] Yamamoto, Y., Role of active oxygen species and antioxidants in photoaging. J. Dermatol . Sci . 27, pp.S1-S4, 2001.Yamamoto, Y., Role of active oxygen species and antioxidants in photoaging. J. Dermatol . Sci . 27 , pp. S1-S4, 2001.

[문헌 3] Sung Mok Beak, Yong Soo Lee, Jung-Ae Kim , NADPH oxidase and cyclooxygenase mediate the ultraviolet B-induced generation of reactive oxygen species and activation of nuclear factor-kB in HaCaT human keratinocytes. J. Biochem . 86, pp.425-429, 2004.[3] Sung Mok Beak, Yong Soo Lee, Jung-Ae Kim, NADPH oxidase and cyclooxygenase mediate the ultraviolet B-induced generation of reactive oxygen species and activation of nuclear factor-kB in HaCaT human keratinocytes. J. Biochem . 86 , pp. 425-429, 2004.

[문헌 4] Masaki, H., Atsumi, T., Sakurai, H., , Detection of hydrogen peroxide and hydroxyl radicals in murine skin fibroblasts under UVB irradiation. Biochem . Biophys . Res . Commun . 206, pp.474-479, 1995.Masaki, H., Atsumi, T., Sakurai, H.,, Detection of hydrogen peroxide and hydroxyl radicals in murine skin fibroblasts under UVB irradiation. Biochem . Biophys . Res . Commun . 206 , pp. 474-479, 1995.

[문헌 5] Karin, M., Liu, Z.-G., Zandi, E., AP-1 function and regulation. Curr. Opin . Cell . Biol . 9, pp.240-246, 1997.Document 5 Karin, M., Liu, Z.-G., Zandi, E., AP-1 function and regulation. Curr. Opin . Cell . Biol . 9 , pp. 240-246, 1997.

[문헌 6] Barber, L.A., Spandau, D.F., Rathman, S.C., Murphy, R.C., Johnson, C.A., Kelly, S.W., Hurwitz, S.A., Travers, J.B., , Expression of the platelet-activating receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line. J. Biol . chem . 273, pp.18891-18897, 1998.[6] Barber, LA, Spandau, DF, Rathman, SC, Murphy, RC, Johnson, CA, Kelly, SW, Hurwitz, SA, Travers, JB,, Expression of the platelet-activating receptor results in enhanced ultraviolet B radiation -induced apoptosis in a human epidermal cell line. J. Biol . chem . 273 , pp. 18891-18897, 1998.

[문헌 7] Lee K S, Lee W S, Suh SI, Kim S P, Lee S R, Ryoo Y W, Kim B C. Melatonin reduces ultraviolet-B induced cell damages and polyamine levels in human skin fibroblasts in culture. Exp Mol Med . 35(4):pp.263-8, 2003.Literature 7 Lee KS, Lee WS, Suh SI, Kim SP, Lee SR, Ryoo YW, Kim B C. Melatonin reduces ultraviolet-B induced cell damages and polyamine levels in human skin fibroblasts in culture. Exp Mol Med . 35 (4) : pp.263-8, 2003.

[문헌 8] Millis, A.J.T., Hoyle, M.,McCue, H.M., Martini, H., ,Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp . Cell . Res . 201, pp.373-379, 1992.Millis, AJT, Hoyle, M., McCue, HM, Martini, H.,, Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp . Cell . Res . 201 , pp. 373-379, 1992.

[문헌 9] Cha, H.J., Bae, S.K., Lee, H.Y., Lee, O.H., sato, H., Seiki, M., Park, B.C, kim, K.W., , Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9(MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res . 56, pp.2281-2284, 1996.9, Cha, HJ, Bae, SK, Lee, HY, Lee, OH, sato, H., Seiki, M., Park, BC, kim, KW,, Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res . 56 , pp. 2281-2284, 1996.

[문헌 10] Brenneisen, P., Wenk, J., Klotz. L.O., Wlaschek, M., Briviba, K., Krieg, T., Sies, H., Scharffetter-Kochanek, K., Central role of ferrous/ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J. Biol . Chem . 273, PP.5279-5287, 1998.10. Brenneisen, P., Wenk, J., Klotz. LO, Wlaschek, M., Briviba, K., Krieg, T., Sies, H., Scharffetter-Kochanek, K., Central role of ferrous / ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloproteinase (MMP) -1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J. Biol . Chem . 273 , pp. 5279-5287, 1998.

[문헌 11] Yong-Sam Keum, Kwang-Kyun Park, Jong-Min Lee, Kyung-soo Chun., Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. J. Cancer Letters . 150, PP.41-48, 2000.[11] Yong-Sam Keum, Kwang-Kyun Park, Jong-Min Lee, Kyung-soo Chun., Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. J. Cancer Letters . 150 , pp. 41-48, 2000.

[문헌 12] Young C. Kim, So R. Kim, George J. Markelonis, Tae H. Oh., Ginsenosides Rb1 and Rg3 Protect Cultured Rat Cortical Cells From Glutamate-Induced Neurodegeneration. J. Neuroscience Res . 53, PP.426-432, 1998.12. Young C. Kim, So R. Kim, George J. Markelonis, Tae H. Oh., Ginsenosides Rb1 and Rg3 Protect Cultured Rat Cortical Cells From Glutamate-Induced Neurodegeneration. J. Neuroscience Res . 53 , pp. 426-432, 1998.

[문헌 13] Keun Young Jung, Dong seon Kim, Platelet Activating Factor Antagonist Activity of Ginsenosides. Biol . Pharm . Bull . 21. PP.79-80, 1998.Keun Young Jung, Dong seon Kim, Platelet Activating Factor Antagonist Activity of Ginsenosides. Biol . Pharm . Bull . 21 . PP. 79-80, 1998.

[문헌 14] 대한민국 특허 10-0192678 약효가 증강된 가공인삼제품, 1999
[Document 14] Korean Patent 10-0192678 Processed Ginseng Product with Enhanced Drug Effect, 1999

오존층의 파괴와 같은 지구환경 변화로 인해 피부는 자외선에 더 많이 노출되고 있다. 자외선(UV)은 그 파장에 따라 UVA, UVB, UVC로 나눌 수 있으며 이 중 UVB는 주로 표피에 영향을 주어 피부손상을 일으킨다(1). 피부표면의 각질세포 (keratinocyte)는 UVB에 직접적으로 노출되어 가장 많은 영향을 받게 된다. 자외선에 노출된 피부에서는 다양한 경로를 통해 활성산소(ROS, Reaction Oxygen Species)가 생성되며, 과도하게 생성된 활성 산소는 피부에 산화적 스트레스를 초래하게 된다. 활성산소(ROS, reaction oxygen species)는 궁극적으로 피부 노화와 홍반, 부종 등의 피부 염증을 유발하고, 심하면 피부암을 유발한다(2). ROS는 superoxide anion, hydrogen peroxide, hydroxyl radical 등이 있는데, 이들은 세포내 산소호흡과정에서 NADPH cytochrome P450 reductase, NADPH oxidase, lipoxygenase 등에 의해 생성되며, 대부분 생체방어 기전에 의해 제거된다(3-4). Global environmental changes, such as the destruction of the ozone layer, make skin more exposed to ultraviolet light. Ultraviolet rays (UV) can be classified into UVA, UVB, and UVC according to their wavelength. Among them, UVB mainly affects the epidermis and causes skin damage (1). Keratinocytes on the skin surface are most affected by direct exposure to UVB. In the skin exposed to ultraviolet rays, reactive oxygen species (ROS) are produced through various pathways, and excessively generated free radicals cause oxidative stress on the skin. Reactive oxygen species (ROS) ultimately lead to skin aging and skin inflammation such as erythema and edema, and severe skin cancer (2). ROS include superoxide anion, hydrogen peroxide, and hydroxyl radical, which are produced by NADPH cytochrome P450 reductase, NADPH oxidase, and lipoxygenase during intracellular oxygen respiration (3-4).

그러나, 자외선에 의해 증가된 활성산소류는 세포조직에 손상을 주어 염증을 유발하며 피부 노화의 원인으로 작용할 수 있다. 이와는 함께 UV는 세포내 신호전달계인 MAPK(mitogen, activated protein kinase), PKC(protein kinase C)의 활성화와 AP-1, NF-κB등의 전사인자 (transcription factors) 활성화를 통해 세포의 단백질 발현에 영향을 준다(5). 케라티노사이트(Keratinocyte)에서 유리되는 TGFβ, PGE2, α-MSH는 UV에 의해 증가하며, 이들은 멜라노사이트(melanocyte)를 활성화시켜 멜라닌(melanin) 생합성을 증가시킨다(6-7). 또한, UV에 의해 피부 각질세포로 부터 유리가 증가되는 TNFα, IL-1등은 피부 진피세포인 진피 섬유아세포 (dermal fibroblast)에 작용하여 MMP-1 (martrix metalloproteinase-1), TIMP-1 (tissue inhibitor of metalloproteinase -1), 프로콜라겐 (procollagen) 등의 생합성을 변화시킨다(8-9). 즉, MMP-1과 같은 단백질 분해효소 유리를 증가시켜 콜라겐(collagen)을 분해시키고, 콜라겐 합성은 억제하여 피부노화를 유발한다(10). However, free radicals increased by UV rays damage cellular tissues and cause inflammation and may cause skin aging. At the same time, UV may be activated by the activation of intracellular signaling systems such as MAPK (mitogen, activated protein kinase) and PKC (protein kinase C) and transcription factors such as AP-1 and NF-κB. Influence (5). TGF β , PGE 2 and α-MSH released from keratinocytes are increased by UV, which activates melanocytes to increase melanin biosynthesis (6-7). In addition, TNFα and IL-1, which are free from keratinocytes by UV, act on dermal fibroblasts, which are dermal dermal cells, resulting in MMP-1 (martrix metalloproteinase-1) and TIMP-1 (tissue). It alters the biosynthesis of inhibitors of metalloproteinase-1 and procollagen (8-9). In other words, by increasing the release of protease such as MMP-1, collagen (collagen) is degraded, collagen synthesis is inhibited to cause skin aging (10).

선삼은 인삼(Panax ginseng)을 고열 고압으로 처리하여 약효가 강한 Rg3, Rg5, Rk1의 함량을 획기적으로 높인 가공 인삼이다. 선삼의 약효로는 항암작용(11), 뇌기능 개선작용(12), 혈소판 응집능 차단작용(13)등이 보고되어있다.Ginseng Panax ginseng ) is a processed ginseng that has dramatically increased the contents of Rg 3 , Rg 5 , and Rk 1 , which are highly effective by treating at high temperature and high pressure. The efficacy of ginseng as an anticancer action (11), brain function improving action (12), platelet aggregation ability blocking action (13) and the like is reported.

본 연구에서는 가공 인삼인 선삼의 추출물을 이용하여 UV에 의한 피부각질세포의 상해작용에 미치는 영향에 대해서 평가하고자 하였다. 이를 위하여 사람의 각질세포인 HaCaT를 자외선 처리하여 LDH, NO 유리를 측정하였으며 COX-2, Bcl-2, Bax, iNOS, COX-2, TNFα, NF-κB, c-fos, c-jun의 유전자 발현에 미치는 영향을 평가하였다. The purpose of this study was to evaluate the effects of UV on the injury of skin keratinocytes by extract of ginseng, a processed ginseng. For this, LDC and NO glass were measured by UV treatment of human keratinocytes, HaCaT, and genes of COX-2, Bcl-2, Bax, iNOS, COX-2, TNFα, NF-κB, c-fos, and c-jun The effect on expression was evaluated.

상기 목적을 달성하기 위하여, 본 발명은 가공된 파낙스속 인삼 추출물을 유효성분으로 함유하는 피부 노화 방지용 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition for preventing skin aging containing the processed Panax ginseng extract as an active ingredient.

따라서, 본 발명은 진세노사이드 Rb1, Rb2, Rc, Rd의 함량의 합보다도 진세노사이드 Rg3, Rg5, Rk1의 함량의 합이 더 높은 가공된 파낙스속 인삼 추출물을 유효성분으로 함유하는 피부 노화 방지용 화장료 조성물을 제공한다.Therefore, the present invention is for preventing skin aging containing a processed Panax ginseng extract, which has a higher sum of the contents of ginsenosides Rg3, Rg5, Rk1 than the sum of the contents of ginsenosides Rb1, Rb2, Rc, and Rd as an active ingredient. It provides a cosmetic composition.

구체적으로, 본원에서 개시된 파낙스속 인삼 추출물은 진세노사이드 Rb1, Rb2, Rc, Rd의 함량의 합보다도 진세노사이드 Rg3, Rg5, Rk1의 함량의 합이 더 높은, 바람직하게는 진세노사이드 (Rg3+Rg5)/(Rc+Rd+Rb₁+Rb₂)의 비율이 1.0이상, 보다 바람직하게는 3.0 이상, 보다 더 바람직하게는 5.0 이상임을 특징으로 한다.Specifically, Panax ginseng extract disclosed herein has a higher sum of the contents of ginsenosides Rg3, Rg5, Rk1 than the sum of the contents of ginsenosides Rb1, Rb2, Rc, Rd, preferably ginsenosides (Rg3). The ratio of + Rg5) / (Rc + Rd + Rb₁ + Rb2) is 1.0 or more, more preferably 3.0 or more, even more preferably 5.0 or more.

구체적으로 또한 본 발명의 상기 가공된 파낙스속 인삼 추출물은 파낙스속 식물을 세절하여 가압멸균기에 넣고 70 ℃ 내지 150 ℃에서, 약 2 내지 30기압 하에서 약 1시간 내지 24시간 동안 가열하여 얻어지는 추출물임을 특징으로 한다.Specifically, the processed Panax ginseng extract of the present invention is an extract obtained by cutting the Panax genus plant into a autoclave and putting it in an autoclave at 70 ° C. to 150 ° C. for about 1 hour to 24 hours under about 2 to 30 atmospheres. It is done.

보다 구체적으로 또한 본 발명의 상기 가공된 파낙스속 인삼 추출물은 파낙스속 식물을 세절하여 가압멸균기에 넣고 70 ℃ 내지 150 ℃에서, 약 2 내지 30기압 하에서 약 1시간 내지 24시간 동안 가열한 후, 시료 중량의 약 1배 내지 20배 중량비(w/w)의 물, C1 내지 C4의 저급 알콜 또는 이들의 혼합용매로, 냉침추출, 열수추출, 초음파 추출, 환류냉각추출, 또는 가열추출 법으로 추출한 후, 그 여과물을 여과하고 감압농축 및 건조하는 단계를 포함하는 공정을 통하여 수득되는 인삼 가공 추출물임을 특징으로 한다.More specifically, the processed Panax ginseng extract of the present invention, after cutting the Panax genus plants in the autoclave and heated at 70 ℃ to 150 ℃, about 2 to 30 atm for about 1 hour to 24 hours, the sample About 1 to 20 times the weight ratio (w / w) of water, C 1 to C 4 lower alcohols, or a mixed solvent thereof, by cold extraction, hot water extraction, ultrasonic extraction, reflux cooling extraction, or heating extraction After extraction, the filtrate is characterized in that the ginseng processed extract obtained through a process comprising the step of filtration and concentration under reduced pressure and drying.

또한 본원에서 정의되는 “파낙스속 인삼”은 통상적으로 상용되는 인삼일 수 있으며, 바람직하게는 인삼(Panax ginseng C.A. Meyer), 화기삼(Panax quinquefolium), 전칠삼 (Panax notoginseng), 죽절삼 (Panax japonicum), 삼엽삼 (Panax trifolium) 또는 히말라야삼 (Panax pseudoginseng) 등과 같은 파낙스속 인삼을 포함한다.In addition, “panax ginseng” as defined herein may be commonly used ginseng, preferably ginseng (Panax ginseng CA Meyer), Panax quinquefolium, Panax notoginseng, Panax japonicum, Panax ginseng, such as Panax trifolium or Himalayan ginseng.

본 발명은 상기의 제조공정으로 얻어진 가공인삼 추출물을 유효성분으로 함유하는 피부 노화 방지용 조성물을 제공한다.The present invention provides a composition for preventing skin aging containing the processed ginseng extract obtained by the above manufacturing process as an active ingredient.

따라서, 본 발명은 건조된 인삼을 세절하여 가압멸균기에 넣고 70 ℃ 내지 150 ℃, 바람직하게는 100 ℃ 내지 130 ℃에서, 약 10 내지 30기압, 바람직하게는 13 내지 18 기압하에서 약 1시간 내지 24시간, 바람직하게는 3시간 내지 5시간 동안 가열한 후, 시료 중량의 약 1배 내지 20배, 바람직하게는 약 3배 내지 10배의 중량비(w/w)의 물, C1 내지 C4의 저급 알콜 또는 이들의 혼합용매, 바람직하게는 물 및 에탄올 혼합용매로, 냉침추출, 열수추출, 초음파 추출, 환류냉각추출, 가열추출 등의 추출방법, 바람직하게는 환류냉각추출 법으로 추출한 후, 그 여과물을 여과하고 감압농축 및 건조하는 단계를 포함하는 공정을 통하여 수득되는 인삼 가공 추출물을 유효성분으로 함유하는 피부 노화 방지용 화장료 조성물을 제공한다.Therefore, the present invention The dried ginseng is chopped and placed in an autoclave, at 70 ° C. to 150 ° C., preferably at 100 ° C. to 130 ° C., at about 10 to 30 atm, preferably at 13 to 18 atm, for about 1 to 24 hours, preferably After heating for 3 to 5 hours, a weight ratio (w / w) of water of about 1 to 20 times, preferably about 3 to 10 times the weight of the sample, C 1 to C 4 lower alcohols or their With a mixed solvent, preferably a mixed solvent of water and ethanol, extracted by cold extraction, hot water extraction, ultrasonic extraction, reflux cooling extraction, heating extraction, preferably reflux cooling extraction, and the filtrate is filtered. It provides a cosmetic composition for preventing skin aging containing ginseng processed extract obtained through a process comprising the step of concentration under reduced pressure and drying as an active ingredient.

상기 가공인삼 추출물의 피부 노화 방지용 화장료 조성물은, 조성물 총 중량에 대하여 상기 추출물을 0.001 내지 90 중량%, 바람직하게는 0.01 내지 10 중량%로 사용이 가능하다. The cosmetic composition for preventing skin aging of the processed ginseng extract may be used in an amount of 0.001 to 90% by weight, preferably 0.01 to 10% by weight, based on the total weight of the composition.

또한, 본 발명의 가공인삼 추출물을 포함하는 상기 화장료 조성물은 화장수, 스킨, 로션, 영양로션, 영양크림, 마사지 크림, 에센스, 팩, 클렌징, 세안제, 비누, 트리트먼트, 미용액 등이 있다.In addition, the cosmetic composition comprising the processed ginseng extract of the present invention includes a lotion, skin, lotion, nutrition lotion, nutrition cream, massage cream, essence, pack, cleansing, face wash, soap, treatment, essence.

본 발명의 화장료는 수용성 비타민, 유용성 비타민, 고분자 펩티드, 고분자다당, 스핑고 지질 및 해초 엑기스로 이루어진 군에서 선택된 조성물을 포함한다. 수용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 B1, 비타민 B2, 비타민 B6, 피리독신, 염산피리독신, 비타민 B12, 판토텐산, 니코틴산, 니코틴산아미드, 엽산, 비타민 C, 비타민 H 등을 들 수 있으며, 그들의 염 (티아민염산염, 아스코르빈산나트륨염 등)이나 유도체 (아스코르빈산-2-인산나트륨염, 아스코르빈산-2-인산마그네슘염 등)도 본 발명에서 사용할 수 있는 수용성 비타민에 포함된다. 수용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 수득할 수 있다. Cosmetics of the present invention comprises a composition selected from the group consisting of water-soluble vitamins, oil-soluble vitamins, polymer peptides, polysaccharides, sphingolipids and seaweed extract. The water-soluble vitamins may be any compound that can be incorporated into cosmetics, but preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine, vitamin B12, pantothenic acid, nicotinic acid, nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like. Their salts (thiamine hydrochloride, sodium ascorbate salt, etc.) and derivatives (ascorbic acid-2-sodium phosphate salt, ascorbic acid-2-magnesium phosphate salt, etc.) may also be used in the water-soluble vitamins that can be used in the present invention. Included. The water-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification from microorganism culture, enzyme or chemical synthesis.

유용성 비타민으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 비타민 A, 카로틴, 비타민 D2, 비타민 D3, 비타민 E (DL-알파 토코페롤, D-알파 토코페롤, D-알파 토코페롤) 등을 들 수 있으며, 그들의 유도체 (팔미틴산아스코르빈, 스테아르산아스코르빈, 디팔미틴산아스코르빈, 아세트산 DL-알파토코페롤, 니코틴산 DL-알파 토코페롤비타민 E. DL-판토테닐알코올, D-판토테닐알코올, 판토테닐에틸에테르 등)도 본 발명에서 사용되는 유용성 비타민에 포함된다. 유용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소 또는 화학 합성법 등의 통상의 방법에 의해 취득할 수 있다. The oil-soluble vitamin may be any compound that can be incorporated into cosmetics, but preferably vitamin A, carotene, vitamin D2, vitamin D3, vitamin E (DL-alpha tocopherol, D-alpha tocopherol, D-alpha tocopherol), and the like. , Derivatives thereof (ascorbic palmitate, ascorbic stearate, ascorbic acid dipalmitate, DL-alphatocopherol acetate, DL-alpha tocopherolvitamin E. DL-pantothenyl alcohol, D-pantothenyl alcohol, pantothenylethyl nicotinic acid) Ethers, etc.) are also included in the oil-soluble vitamins used in the present invention. Oil-soluble vitamins can be obtained by conventional methods such as microbial transformation, purification of microorganism culture, enzyme or chemical synthesis.

고분자 펩티드로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 콜라겐, 가수분해 콜라겐, 젤라틴, 엘라스틴, 가수분해 엘라스틴, 케라틴 등을 들 수 있다. 고분자 펩티드는 미생물의 배양액으로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 정제 취득할 수 있으며, 또는 통상 돼지나 소 등의 진피, 누에의 견섬유 등의 천연물로부터 정제하여 사용할 수 있다. The polymer peptide may be any compound as long as it can be incorporated into cosmetics. Preferably, collagen, hydrolyzed collagen, gelatin, elastin, hydrolyzed elastin, keratin and the like can be given. Polymeric peptides can be purified and obtained by conventional methods such as purification from microbial cultures, enzymatic methods or chemical synthesis methods, or can be purified and used from natural products such as dermis and pig silk such as pigs and cattle.

고분자 다당으로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 히드록시에틸셀룰로오스, 크산탄검, 히알루론산나트륨, 콘드로이틴 황산 또는 그 염 (나트륨염 등) 등을 들 수 있다. 예를 들어, 콘드로이틴 황산 또는 그 염 등은 통상 포유 동물이나 어류로부터 정제하여 사용할 수 있다.The polymer polysaccharide may be any compound as long as it can be blended into cosmetics. Preferably, hydroxyethyl cellulose, xanthan gum, sodium hyaluronate, chondroitin sulfate or a salt thereof (sodium salt, etc.) may be mentioned. For example, chondroitin sulfate or its salt can be normally purified from a mammal or fish.

스핑고 지질로서는 화장품에 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 세라미드, 피토스핑고신, 스핑고당지질 등을 들 수 있다. 스핑고 지질은 통상 포유류, 어류, 패류, 효모 또는 식물 등으로부터 통상의 방법에 의해 정제하거나 화학 합성법에 의해 취득할 수 있다.The sphingolipid may be any compound as long as it can be blended into cosmetics. Preferably, ceramide, phytosphingosine, sphingosaccharide lipid, etc. may be mentioned. Sphingo lipids can usually be purified from mammals, fish, shellfish, yeasts or plants by conventional methods or obtained by chemical synthesis.

해초 엑기스로는 화장품 배합 가능한 것이라면 어떠한 것이라도 되지만, 바람직하게는 갈조 엑기스, 홍조 엑기스, 녹조 엑기스 등을 들 수 있으며, 또, 이들의 해초 엑기스로부터 정제된 칼라기난, 아르긴산, 아르긴산나트륨, 아르긴산칼륨 등도 본 발명에서 사용되는 해초 엑기스에 포함된다. 해초 엑기스는 해초로부터 통상의 방법에 의해 정제하여 취득할 수 있다. The seaweed extract may be any compound as long as it can be cosmetically blended. Preferably, seaweed extract may include brown algae extract, red algae extract, green algae extract, and the like, and calginane, arginic acid, sodium arginate and argin purified from these seaweed extracts. Potassium ginate and the like are also included in the seaweed extract used in the present invention. Seaweed extract can be obtained by purification from seaweed by conventional methods.

본 발명의 화장료에는 상기 필수 성분과 더불어 필요에 따라 통상 화장료에 배합되는 다른 성분을 배합해도 된다. The cosmetic of the present invention may be blended with other essential ingredients, if necessary, in combination with the essential ingredients.

이외에 첨가해도 되는 배합 성분으로서는 유지 성분, 보습제, 에몰리엔트제, 계면활성제, 유기 및 무기 안료, 유기 분체, 자외선 흡수제, 방부제, 살균제, 산화 방지제, 식물 추출물, pH 조정제, 알콜, 색소, 향료, 혈행 촉진제, 냉감제, 제한제, 정제수 등을 들 수 있다.Other components that may be added include fats and oils, humectants, emollients, surfactants, organic and inorganic pigments, organic powders, ultraviolet absorbers, preservatives, fungicides, antioxidants, plant extracts, pH adjusters, alcohols, pigments, flavorings, Blood circulation accelerators, cooling agents, limiting agents, purified water and the like.

유지 성분으로서는 에스테르계 유지, 탄화수소계 유지, 실리콘계 유지, 불소계 유지, 동물 유지, 식물 유지 등을 들 수 있다.Examples of the fat or oil component include ester fats, hydrocarbon fats, silicone fats, fluorine fats, animal fats, and vegetable fats and oils.

에스테르계 유지로서는 트리2-에틸헥산산글리세릴, 2-에틸헥산산세틸, 미리스틴산이소프로필, 미리스틴산부틸, 팔미틴산이소프로필, 스테아르산에틸, 팔미틴산옥틸, 이소스테아르산이소세틸, 스테아르산부틸, 리놀레산에틸, 리놀레산이소프로필, 올레인산에틸, 미리스틴산이소세틸, 미리스틴산이소스테아릴, 팔미틴산이소스테아릴, 미리스틴산옥틸도데실, 이소스테아르산이소세틸, 세바신산디에틸, 아디핀산디이소프로필, 네오펜탄산이소알킬, 트리 (카프릴, 카프린산) 글리세릴, 트리2-에틸헥산산트리메틸롤프로판, 트리이소스테아르산트리메틸롤프로판, 테트라2-에틸헥산산펜타엘리슬리톨, 카프릴산세틸, 라우린산데실, 라우린산헥실, 미리스틴산데실, 미리스틴산미리스틸, 미리스틴산세틸, 스테아르산스테아릴, 올레인산데실, 리시노올레인산세틸, 라우린산이소스테아릴, 미리스틴산이소트리데실, 팔미틴산이소세틸, 스테아르산옥틸, 스테아르산이소세틸, 올레인산이소데실, 올레인산옥틸도데실, 리놀레산옥틸도데실, 이소스테아르산이소프로필, 2-에틸헥산산세토스테아릴, 2-에틸헥산산스테아릴, 이소스테아르산헥실, 디옥탄산에틸렌글리콜, 디올레인산에틸렌글리콜, 디카프린산프로필렌글리콜, 디 (카프릴, 카프린산) 프로필렌글리콜, 디카프릴산프로필렌글리콜, 디카프린산네오펜틸글리콜, 디옥탄산네오펜틸글리콜, 트리카프릴산글리세릴, 트리운데실산글리세릴, 트리이소팔미틴산글리세릴, 트리이소스테아르산글리세릴, 네오펜탄산옥틸도데실, 옥탄산이소스테아릴, 이소노난산옥틸, 네오데칸산헥실데실, 네오데칸산옥틸도데실, 이소스테아르산이소세틸, 이소소테아르산이소스테아릴, 이소스테아르산옥틸데실, 폴리글리세린올레인산에스테르, 폴리글리세린이소스테아르산에스테르, 시트르산트리이소세틸, 시트르산트리이소알킬, 시트르산트리이소옥틸, 락트산라우릴, 락트산미리스틸, 락트산세틸, 락트산옥틸데실, 시트르산트리에텔, 시트르산아세틸트리에틸, 시트르산아세틸트리부틸, 시트르산트리옥틸, 말산디이소스테아릴, 히드록시스테아르산 2-에틸헥실, 숙신산디2-에틸헥실, 아디핀산디이소부틸, 세바신산디이소프로필, 세바신산디옥틸, 스테아르산콜레스테릴, 이소스테아르산콜레스테릴, 히드록시스테아르산콜레스테릴, 올레인산콜레스테릴, 올레인산디히드로콜레스테릴, 이소스테아르산피트스테릴, 올레인산피트스테릴, 12-스테알로일히드록시스테아르산이소세틸, 12-스테알로일히드록시스테아르산스테아리리, 12-스테알로일히드록시스테아르산이소스테아릴 등의 에스테르계 등을 들 수 있다.As ester fats and oils, glyceryl tri2-ethylhexanoate, cetyl 2-ethylhexanoate, isopropyl myristate, butyl mystinate, isopropyl palmitate, ethyl stearate, octyl palmitate, isocetyl isostearate, and stearic acid Butyl, ethyl linoleate, isopropyl linoleate, ethyl oleate, isocetyl acid isocetyl, isostyl acid isostearyl, isostaryl palmitate, octylate acid octyldodecyl, isostearic acid isetyl, diethyl sebacate, adipine Acid isopropyl, isoalkyl neopentane, tri (capryl, capric acid) glyceryl, trimethyl ethyl trimethylolpropane, trimethyl stearate trimethylol propane, tetra 2-ethylhexanopenta lysitol Cetyl caprylate, lauric acid decyl, hexyl laurate, decyl myristin, myristin acid myristyl, myritic acid cetyl, stearyl stearate, decyl oleate, lysinooleic acid Teyl, isostearyl laurate, isotridecyl myristin, isocetyl palmitate, octyl stearate, isocetyl stearate, isodecyl oleate, octyl dodecyl oleate, octyl dodecyl linoleate, isopropyl isopropyl acid, 2-ethylhexanoic acid cetostearyl, 2-ethylhexanoic acid stearyl, hexyl isostearate, ethylene glycol dioctanoate, ethylene glycol dioleate, propylene glycol dicapric acid, propylene glycol di (capryl, capric acid), Dicaprylic acid propylene glycol, dicapric acid neopentyl glycol, dioctanoate neopentyl glycol, tricaprylate glyceryl, triundecyl glyceryl, triisopalmitinate glyceryl, triisostearate glyceryl, octylate octadodode Sil, isostearyl octanoate, octyl isononate, hexyl decyl neodecanoate, octyl dodecyl neodecanoate, isocetyl isostearate, isostearate isostearic acid , Isostearic acid octyldecyl, polyglycerol oleic acid ester, polyglycerol isostearic acid ester, triisocetyl citrate, triisoalkyl citrate, triisooctyl citrate, lauric lactate, myristyl lactate, cetyl lactate, octyldecyl lactate, citric acid Triether, acetyl triethyl citrate, acetyl tributyl citrate, trioctyl citrate, diisostearyl malic acid, 2-ethylhexyl hydroxystearate, di2-ethylhexyl succinate, diisobutyl adipicate, diisopropyl sebacinate Dioctyl sebacate, stearic acid cholesterol, isostearic acid cholesterol, hydroxystearate cholesterol, oleic acid cholesteryl, oleic acid dihydrocholesteryl, isostearic acid phyteryl, phosphate oleate , 12-stealoyl hydroxystearate isocetyl, 12-stealoyl hydroxystearate stearic acid, 12-s Allo one hydroxy stearic acid and the like esters such as cetearyl source.

탄화 수소계 유지로서는 스쿠알렌, 유동 파라핀, 알파-올레핀올리고머, 이소파라핀, 세레신, 파라핀, 유동 이소파라핀, 폴리부덴, 마이크로크리스탈린왁스, 와셀린 등의 탄화 수소계 유지 등을 들 수 있다.Hydrocarbon-based fats and oils, such as squalene, a liquid paraffin, alpha-olefin oligomer, isoparaffin, ceresin, paraffin, a liquid isoparaffin, polybutene, microcrystal wax, and a vaseline, etc. are mentioned as a hydrocarbon-type fats and oils.

실리콘계 유지로서는 폴리메틴실리콘, 메틸페닐실리콘, 메틸시클로폴리실록산, 옥타메틸폴리실록산, 데카메틸폴리실록산, 도데카메틸시클로실록산, 디메틸실록산메틸세틸옥시실록산 공증합체, 디메틸실록산메틸스테알록시실록산 공중합체, 알킬 변성 실리콘유, 아미노 변성 실리콘유 등을 들 수 있다. As silicone fats and oils, polymethine silicone, methylphenyl silicone, methylcyclopolysiloxane, octamethyl polysiloxane, decamethyl polysiloxane, dodecamethylcyclosiloxane, dimethylsiloxane methylcetyloxysiloxane copolymer, dimethylsiloxane methyl steoxysiloxane copolymer, and alkyl modified silicone Oil, amino modified silicone oil, etc. are mentioned.

불소계 유지로서는 퍼플루오로폴리에테르 등을 들 수 있다.Examples of the fluorine-based oil include perfluoropolyether and the like.

동물 또는 식물 유지로서는 아보카도유, 아몬드유, 올리브유, 참깨유, 쌀겨유, 새플라워유, 대두유, 옥수수유, 유채유, 행인유, 팜핵유, 팜유, 피마자유, 해바라기유, 포도종자유, 면실유, 야자유, 쿠쿠이너트유, 소맥배아유, 쌀배아유, 시아버터, 월견초유, 마커데이미아너트유, 메도홈유, 난황유, 우지마유, 밍크유, 오렌지라피유, 호호바유, 캔데리러왁스, 카르나바왁스, 액상 라놀린, 경화피마자유 등의 동물 또는 식물 유지를 들 수 있다.As animal or vegetable fats and oils, avocado oil, almond oil, olive oil, sesame oil, rice bran oil, soybean oil, soybean oil, corn oil, rapeseed oil, almond oil, palm kernel oil, palm oil, castor oil, sunflower oil, grape seed oil, cottonseed oil, palm oil , Cucumber nut oil, Wheat germ oil, Rice germ oil, Shea butter, Walnut colostrum, Marker demia nut oil, Meadow home oil, Egg yolk oil, Ujima oil, Mink oil, Orange rape oil, Jojoba oil, Canderry wax, Carnabas wax And animal or plant fats and oils, such as liquid lanolin and hardened castor oil.

보습제로서는 수용성 저분자 보습제, 지용성 분자 보습제, 수용성 고분자, 지용성 고분자 등을 들 수 있다.Examples of the moisturizing agent include a water-soluble low molecular moisturizer, a fat-soluble molecular moisturizer, a water-soluble polymer, and a fat-soluble polymer.

수용성 저분자 보습제로서는 세린, 글루타민, 솔비톨, 만니톨, 피롤리돈-카르복실산타느륨, 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 에틸렌글리콜, 폴리에틸렌글리콜B (중합도 n=2 이상), 폴리프로필렌글리콜 (중합도 n=2 이상), 폴리글리세린B (중합도 n=2 이상), 락트산, 락트산염 등을 들 수 있다. 지용성 저분자 보습제로서는 콜레스테롤, 콜레스테롤에스테르 등을 들 수 있다. 수용성 고분자로서는 카르복시비닐폴리머, 폴리아스파라긴산염, 트라가칸트, 크산탄검, 메틸셀룰로오스, 히드록시메틸셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 카르복시메틸셀룰로오스, 수용성 키틴, 키토산, 덱스트린 등을 들 수 있다. 지용성 고분자로서는 폴리비닐피롤리돈· 에이코센 공중합체, 폴리비닐피롤리돈· 헥사데센 공중합체, 니트로셀룰로오스, 덱스트린지방산에스테르, 고분자 실리콘 등을 들 수 있다.As a water-soluble low molecular moisturizer, serine, glutamine, sorbitol, mannitol, pyrrolidone- carboxylate titanium, glycerin, propylene glycol, 1, 3- butylene glycol, ethylene glycol, polyethylene glycol B (polymerization degree n = 2 or more), polypropylene Glycol (polymerization degree n = 2 or more), polyglycerol B (polymerization degree n = 2 or more), lactic acid, lactic acid salt, etc. are mentioned. Examples of the fat-soluble low molecular humectants include cholesterol and cholesterol esters. As the water-soluble polymer, carboxyvinyl polymer, polyasparaginate, tragacanth, xanthan gum, methyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose , Water soluble chitin, chitosan, dextrin and the like. Examples of the fat-soluble polymers include polyvinylpyrrolidone-eicosene copolymers, polyvinylpyrrolidone-hexadecene copolymers, nitrocellulose, dextrin fatty acid esters, polymer silicones, and the like.

에몰리엔트제로서는 장쇄아실글루타민산콜레스테릴에스테르, 히드록시스테아르산콜레스테릴, 12-히드록시스테아르산, 스테아르산, 로진산, 라놀린지방산콜레스테릴에스테르 등을 들 수 있다.Examples of the emollient include long-chain acyl glutamic acid cholesteryl esters, hydroxy stearic acid cholesterol, 12-hydroxystearic acid, stearic acid, rosin acid, lanolin fatty acid cholesteryl esters, and the like.

계면 활성제로서는 비이온성 계면 활성제, 음이온성 계면 활성제, 양이온성 계면 활성제, 양성 계면 활성제 등을 들 수 있다. As surfactant, nonionic surfactant, anionic surfactant, cationic surfactant, amphoteric surfactant, etc. are mentioned.

비이온성 계면 활성제로서는 자기 유화형 모노스테아르산글리세린, 프로필렌글리콜지방산에스테르, 글리세린지방산에스테르, 폴리글리세린지방산에스테르, 솔비탄지방산에스테르, POE (폴리옥시에틸렌) 솔비탄지방산에스테르, POE 글리세린지방산에스테르, POE 알킬에테르, POE 지방산에스테르, POE 경화피마자유, POE 피마자유, POE· POP (폴리옥시에틸렌ㆍ폴리옥시프로필렌) 공중합체, POE· POP 알킬에테르, 폴리에테르변성실리콘, 라우린산알카놀아미드, 알킬아민옥시드, 수소첨가대두인지질 등을 들 수 있다.Examples of nonionic surfactants are self-emulsifying glycerin monostearate, propylene glycol fatty acid esters, glycerin fatty acid esters, polyglycerol fatty acid esters, sorbitan fatty acid esters, POE (polyoxyethylene) sorbitan fatty acid esters, POE glycerin fatty acid esters, and POE alkyls. Ether, POE fatty acid ester, POE hardened castor oil, POE castor oil, POE POP (polyoxyethylene polyoxypropylene) copolymer, POE POP organic ether, polyether modified silicone, lauric acid alkanolamide, alkylamine Oxide, hydrogenated soybean phospholipid, etc. are mentioned.

음이온성 계면 활성제로서는 지방산비누, 알파-아실술폰산염, 알킬술폰산염, 알킬알릴술폰산염, 알킬나프탈렌술폰산염, 알킬황산염, POE 알킬에테르황산염, 알킬아미드황산염, 알킬인산염, POE 알킬인삼염, 알킬아미드인산염, 알킬로일알킬타우린염, N-아실아미노산염, POE 알킬에테르카르복실산염, 알킬술포숙신산염, 알킬술포아세트산나트륨, 아실화 가수분해 콜라겐펩티드염, 퍼플루오로알킬인산에스테르 등을 들 수 있다.Anionic surfactants include fatty acid soaps, alpha-acyl sulfonates, alkyl sulfonates, alkyl allyl sulfonates, alkyl naphthalene sulfonates, alkyl sulfates, POE alkyl ether sulfates, alkylamide sulfates, alkyl phosphates, POE alkylphosphates, and alkylamides. Phosphates, alkyloylalkyltaurine salts, N-acylamino acid salts, POE alkyl ether carboxylate salts, alkyl sulfosuccinate salts, sodium alkyl sulfo acetates, acylated hydrolyzed collagen peptide salts, perfluoroalkyl phosphate esters, and the like. have.

양이온성 계면 활성제로서는 염화알킬트리에틸암모늄, 염화스테아릴트리메틸암모늄, 브롬화스테아릴트리메틸암모늄, 염화세토스테아릴트리메틸암모늄, 염화디스테아릴디메틸암모늄, 염화스테아릴디메틸멘질암모늄, 보름화베헤닐트리메틸암모늄, 염화벤잘코늄, 스테아르산디에틸아미노에틸아미드, 스테아르산디메틸아미노프로필아미드, 라놀린 유도체 제 4급 암모늄염 등을 들 수 있다.Examples of cationic surfactants include alkyltriethylammonium chloride, stearyltrimethylammonium chloride, stearyl trimethylammonium chloride, cetostearyltrimethylammonium chloride, distearyldimethylammonium chloride, stearyldimethylmenzyl ammonium, behenyltrimethylammonium, Benzalkonium chloride, diethylaminoethyl stearate, dimethylaminopropyl stearate, lanolin derivatives, quaternary ammonium salts, and the like.

양성 계면 활성제로서는 카르복시베타인형, 아미드베타인형, 술포베타인형, 히드록시술포베타인형, 아미드술포베타인형, 포스포베타인형, 아미노카르복실산염형, 이미다졸린 유도체형, 아미드아민형 등의 양성 계면 활성제 등을 들 수 있다.Examples of amphoteric surfactants include the carboxybetaine type, the amide betain type, the sulfobetain type, the hydroxysulfobetain type, the amide sulfobetain type, the phosphobetaine type, the aminocarboxylate type, the imidazoline derivative type, and the amideamine type. An amphoteric surfactant etc. are mentioned.

유기 및 무기 안료로서는 규산, 무수규산, 규산마그네슘, 탤크, 세리사이트, 마이카, 카올린, 벵갈라, 클레이, 벤토나이트, 티탄피막운모, 옥시염화비스무트, 산화지르코늄, 산화마그네슘, 산화아연, 산화티탄, 산화알루미늄, 황산칼슘, 황산바륨, 황산마그네슘, 탄산칼슘, 탄산마그네슘, 산화철, 군청, 산화크롬, 수산화크롬, 칼라민 및 이들의 복합체 등의 무기 안료; 폴리아미드, 폴리에스테르, 폴리프로필렌, 폴리스티렌, 폴리우레탄, 비닐수지, 요소수지, 페놀수지, 불소수지, 규소수지, 아크릴수지, 멜라민수지, 에폭시수지, 폴리카보네이트수지, 디비닐벤젠스티렌 공중합체, 실크파우더, 셀룰로오스, CI 피그먼트옐로우, CI 피그먼트오렌지 등의 유기 안료 및 이들의 무기 안료와 유기 안료의 복합 안료 등을 들 수 있다.Organic and inorganic pigments include silicic acid, silicic anhydride, magnesium silicate, talc, sericite, mica, kaolin, bengala, clay, bentonite, titanium film mica, bismuth oxychloride, zirconium oxide, magnesium oxide, zinc oxide, titanium oxide, aluminum oxide Inorganic pigments such as calcium sulfate, barium sulfate, magnesium sulfate, calcium carbonate, magnesium carbonate, iron oxide, ultramarine blue, chromium oxide, chromium hydroxide, calamine, and composites thereof; Polyamide, Polyester, Polypropylene, Polystyrene, Polyurethane, Vinyl Resin, Urea Resin, Phenol Resin, Fluoro Resin, Silicon Resin, Acrylic Resin, Melamine Resin, Epoxy Resin, Polycarbonate Resin, Divinylbenzene Styrene Copolymer, Silk Organic pigments such as powder, cellulose, CI pigment yellow, CI pigment orange, and composite pigments of these inorganic pigments and organic pigments;

유기 분체로서는 스테아르산칼슘 등의 금속비누; 세틸린산아연나트륨, 라우릴린산아연, 라우릴린산칼슘 등의 알킬인산금속염; N-라우로일-베타-알라닌칼슘, N-라우로일-베타-알라닌아연, N-라우로일글리신칼슘 등의 아실아미노산 다가금속염; N-라우로일-타우린칼슘, N-팔미토일-타우린칼슘등의 아미드술폰산 다가금속염; N-엡실론-라우로일-L-리진, N-엡실론-팔미토일리진, N-알파-파리토일올니틴, N-알파-라우로일아르기닌, N-알파-경화우지지방산아실아르기닌 등의 N-아실염기성아미노산; N-라우로일글리실글리신 등의 N-아실폴리펩티드; 알파-아미노카프릴산, 알파-아미노라우린산 등의 알파-아미노지방산; 폴리에틸렌, 폴리프로필렌, 나일론, 폴리메틸메타크릴레이트, 폴리스티렌, 디비닐벤젠스티렌 공중합체, 사불화에틸렌 등을 들 수 있다. As organic powder, Metal soaps, such as a calcium stearate; Alkyl phosphate metal salts such as zinc sodium cetyl acid, zinc lauryl acid and calcium laurate; Acylamino acid polyvalent metal salts such as N-lauroyl-beta-alanine calcium, N-lauroyl-beta-alanine zinc, and N-lauroylglycine calcium; Amide sulfonic acid polyvalent metal salts, such as N-lauroyl-taurine calcium and N-palmitoyl-taurine calcium; N-epsilon-lauroyl-L-lysine, N-epsilon-palmitolyzine, N-alpha-paratoylol nitin, N-alpha-lauroyl arginine, N-alpha-cured fatty acid acyl arginine Acyl basic amino acids; N-acylpolypeptides, such as N-lauroyl glycyl glycine; Alpha-amino fatty acids such as alpha-aminocaprylic acid and alpha-aminolauric acid; Polyethylene, polypropylene, nylon, polymethyl methacrylate, polystyrene, divinylbenzene styrene copolymer, ethylene tetrafluoride and the like.

자외선 흡수제로서는 파라아미노벤조산, 파라아미노벤조산에틸, 파라아미노벤조산아밀, 파라아미노벤조산옥틸, 살리실산에틸렌글리콜, 살리신산페닐, 살리신산옥틸, 살리신산벤질, 살리신산부틸페닐, 살리신산호모멘텔, 계피산벤질, 파라메톡시계피산-2-에톡시에틸, 파라메녹시계피산옥틸, 다파라메톡시계피산모노-2-에틸헥산글리세릴, 파라메톡시계피산이소프로필, 디이소프로필디이소프로필계피산에스테르 혼합물, 우로카닌산, 우로카닌산에틸, 히드록시메톡시벤조페논, 히드록시메톡시벤조페논술폰산 및 그 염, 디히드록시메톡시벤조페논, 디히드록시메톡시벤조페논디술폰산나트륨, 디히드록시벤조페논, 테트라히드록시벤조페논, 4-tert-부틸-4‘-메톡시디벤조일메탄, 2,4,6-트리아닐리노-ρ-(카르보-2’-에틸헥실-1‘-옥시)-1,3,5-트리아진, 2-(2-히드록시-5-메틸페닐)벤조트리아졸 등을 들 수 있다.Examples of the ultraviolet absorber include paraaminobenzoic acid, ethyl paraaminobenzoate, amyl paraaminobenzoic acid, octyl paraaminobenzoate, ethylene glycol salicylate, phenyl salicylate, octyl salicylate, benzyl salicylate, butylphenyl salicylate, homomentel salicylic acid and benzyl cinnamic acid. , Paramethoxy cinnamic acid-2-ethoxyethyl, paramethoxy cyanic acid octyl, daparamethoxy cinnamic acid mono-2-ethylhexane glyceryl, paramethoxy cinnamic acid isopropyl, diisopropyl diisopropyl cinnamic acid ester mixture, uro Canonic acid, ethyl urokanoate, hydroxymethoxybenzophenone, hydroxymethoxybenzophenonesulfonic acid and salts thereof, dihydroxymethoxybenzophenone, dihydroxymethoxybenzophenone sodium sulfonate, dihydroxybenzophenone , Tetrahydroxybenzophenone, 4-tert-butyl-4'-methoxydibenzoylmethane, 2,4,6-trianilino-ρ- (carbo-2'-ethylhexyl-1'-oxy) -1 , 3,5-triazine, 2- (2-hi And the like can be mentioned hydroxy-5-methylphenyl) benzotriazole.

살균제로서는 히노키티올, 트리클로산, 트리클로로히드록시디페닐에테르, 크로르헥시딘글루콘산염, 페녹시에탄올, 레조르신, 이소프로필메틸페놀, 아줄렌, 살리칠산, 진크필리티온, 염화벤잘코늄, 감광소 301호, 모노니트로과이어콜나트륨, 운데시렌산 등을 들 수 있다.As fungicides, hinokithiol, trichloric acid, trichlorohydroxydiphenyl ether, chlorhexidine gluconate, phenoxyethanol, resorcin, isopropylmethylphenol, azulene, salicylic acid, ginxitlionone, benzalkonium chloride, photosensitive Sodium No. 301, sodium mononitrohydrol, undecylenic acid, and the like.

산화 방지제로서는 부틸히드록시아니솔, 갈릭산프로필, 엘리소르빈산 등을 들 수 있다.  Examples of the antioxidant include butylhydroxyanisole, propyl gallic acid, and erythorbic acid.

pH 조정제로서는 시트르산, 시트르산나트륨, 말산, 말산나트륨, 프말산, 프말산나트륨, 숙신산, 숙신산나트륨, 수산화나트륨, 인산일수소나트륨 등을 들 수 있다.Examples of the pH adjuster include citric acid, sodium citrate, malic acid, sodium malate, fmaric acid, sodium pmarate, succinic acid, sodium succinate, sodium hydroxide, sodium dihydrogen phosphate, and the like.

알코올로서는 세틸알코올 등의 고급 알코올을 들 수 있다.Examples of the alcohol include higher alcohols such as cetyl alcohol.

또한, 이외에 첨가해도 되는 배합 성분은 이에 한정되는 것은 아니며, 상기 어느 성분도 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 배합 가능하지만, 총중량에 대하여 바람직하게는 0.01 내지 5 중량%, 보다 바람직하게는 0.01 내지 3 중량%로 배합된다.Moreover, the compounding component which may be added other than this is not limited to this, Although any said component can be mix | blended within the range which does not impair the objective and effect of this invention, Preferably it is 0.01-5 weight% with respect to a total weight, More preferably, Is formulated at 0.01 to 3% by weight.

본 발명의 화장료는 용액, 유화물, 점성형 혼합물 등의 형상을 취할 수 있다.The cosmetic of the present invention may take the form of a solution, an emulsion, a viscous mixture or the like.

본 발명의 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함한다.Ingredients included in the cosmetic composition of the present invention may include components commonly used in cosmetic compositions in addition to the extract as an active ingredient, for example, conventional auxiliaries such as stabilizers, solubilizers, vitamins, pigments and flavors and Carrier.

본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 유액, 크림, 화장수, 팩, 파운데이션, 로션, 미용액, 모발화장료 등을 들 수 있다.The cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, and includes, for example, milky lotion, cream, lotion, pack, foundation, lotion, essence, hair cosmetic, and the like.

구체적으로, 본 발명의 화장료 조성물은 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지크림, 영양크림, 모이스처크림, 핸드크림, 파운데이션, 에센스, 영양에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클린저의 제형을 포함한다.Specifically, the cosmetic composition of the present invention skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisturizing lotion, nutrition lotion, massage cream, nutrition cream, moisturizing cream, hand cream, foundation, essence, nutrition essence, Formulations of packs, soaps, cleansing foams, cleansing lotions, cleansing creams, body lotions and body cleansers.

본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, plant fiber, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .

본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.In the case where the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. Especially, in the case of a spray, a mixture of chlorofluorohydrocarbons, propane / Propane or dimethyl ether.

본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1, 3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solvating or emulsifying agent is used as the carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 , Fatty acid esters of 3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.

본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌글리콜과 같은 액상 회석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the dosage form of the present invention is a suspension, liquid carriers such as water, ethanol or propylene glycol, suspensions such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan esters, and microcrystals are used as carrier components. Soluble cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.

본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.
When the formulation of the present invention is a surfactant-containing cleansing, the carrier component is aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide. Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.

본 발명의 선삼 추출물을 함유하는 조성물은 UV로 자극된 피부 각질세포주인 HaCaT의 상해로 인한 LDH 유리를 억제, NO의 생성을 억제, UV에 의한 ROS 관련인자인 iNOS 발현과 전사인자인 c-jun, c-fos, NF-kB 발현을 억제하는 효과를 나타내는 바, UV로 자극된 피부 각질세포를 보호하고, UV에 의한 피부손상 관련인자들을 조절하여 피부손상을 억제하여 피부 노화 방지용 화장료 조성물로 사용될 수 있다.
The composition containing the ginseng extract of the present invention inhibits LDH release due to injury of HaCaT, a skin keratinocyte line stimulated by UV, inhibits NO production, expression of iNOS, a ROS-related factor by UV, and c-jun, a transcription factor. It shows the effect of inhibiting the expression of c-fos and NF-kB. It protects keratinocytes stimulated by UV and controls skin damage related factors by UV to inhibit skin damage and thus be used as a cosmetic composition for preventing skin aging. Can be.

도 1은 선삼 추출물의 UVB에 의한 Nitrite 생성능에 미치는 영향에 관한 도이며,
도 2는 선삼 추출물의 UV 조사에 의한 LDH 유리에 미치는 영향에 관한 도이며,
도 3는 선삼 추출물의 UVB에 의한 COX-2 유전자 발현에 미치는 영향에 관한 도이며,
도 4는 선삼 추출물의 UVB에 의한 TNFα유전자 발현에 미치는 영향에 관한 도이며,
도 5는 선삼 추출물의 UVB에 의한 c-jun 유전자 발현에 미치는 영향에 관한 도이며,
도 6은 선삼 추출물의 UVB에 의한 c-fos 유전자 발현에 미치는 영향에 관한 도이며,
도 7은 선삼 추출물의 UVB에 의한 iNOS 유전자 발현에 미치는 영향에 관한 도이다.
1 is a view of the effect on the production of Nitrite by UVB of ginseng extract,
2 is a diagram showing the effect on the LDH glass by UV irradiation of the ginseng extract,
3 is a diagram showing the effect on the expression of COX-2 gene by UVB of ginseng extract,
4 is a diagram showing the effect on the expression of TNFα gene by UVB of ginseng extract,
Figure 5 is a diagram of the effect on the expression of c-jun gene by UVB of ginseng extract,
6 is a diagram showing the effect on the expression of c-fos gene by UVB of ginseng extract,
Figure 7 is a view of the effect on the expression of iNOS gene by UVB of ginseng extract.

이하, 본 발명을 하기에 의해 상세히 설명한다. Hereinafter, the present invention will be described in detail by the following.

단, 하기 실시예, 참고예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 이에 의해 한정되는 것은 아니다.
However, the following Examples, Reference Examples and Experimental Examples are merely illustrative of the present invention, but the content of the present invention is not limited thereto.

실시예 1. 선삼 추출물의 제조Example 1 Preparation of Ginseng Extract

건조된 인삼(금산 인삼시장)을 잘게 자른 후, 120℃, 15 기압에서 4시간 동안 수증기를 이용하여 가열하였다. 가공된 인삼(이하 “선삼”이라 함) 1 kg에 80% 에탄올 2 L를 가하고 수욕상에서 4시간 이상 환류 추출하여 얻어진 추출물을 감압 농축한 다음 동결 건조하여 추출분말 약 300 g 을 수득하였다. 실험 시에는 선삼 추출물(이하 “SG”라 함)을 DMSO(Sigma D-2650)를 이용하여 배지에 녹인 후, pore size 0.45 ㎛의 여과지를 통과시킨 후 사용하였다. 실험에 사용한 선삼 추출물의 (Rg3 + Rg5 + Rk1)/(Rb1 + Rb2 + Rc + Rd)= 6.1 이었다.
The dried ginseng (Gumsan ginseng market) was chopped and heated using steam at 120 ° C. and 15 atm for 4 hours. 2 L of 80% ethanol was added to 1 kg of processed ginseng (hereinafter referred to as “ginseng”), and the extract obtained by reflux extraction for 4 hours or more in a water bath was concentrated under reduced pressure, and then freeze-dried to obtain about 300 g of an extract powder. In the experiment, the ginseng extract (hereinafter referred to as “SG”) was dissolved in a medium using DMSO (Sigma D-2650), and used after passing a filter paper having a pore size of 0.45 μm. (Rg3 + Rg5 + Rk1) / (Rb1 + Rb2 + Rc + Rd) = 6.1 of the ginseng extract used in the experiment.

실시예 2. 선삼 추출물의 사포닌 함량 분석Example 2. Analysis of Saponin Content of Sea Ginseng Extract

실시예 1에서 얻은 본 발명에 따라 제조된 가공인삼에 함유된 인삼사포닌 성분을 다음과 같은 방법에 의해 분석하였다.The ginseng saponin component contained in the processed ginseng prepared according to the present invention obtained in Example 1 was analyzed by the following method.

40㎖ 용적의 스테인레스 스틸 용기 4개에 각각 백삼 5g과 물 5㎖를 가한 후 밀폐하여 각각 110℃에서 2시간, 120℃에서 2시간 및 3시간 및 130℃에서 2시간 동안 가열하였다. 가열이 끝난 가공인삼, 및 시판품인 백삼 및 홍삼 각 5g 씩을 취하여 메탄올 100㎖씩으로 3회 추출하고 농축시킨 후에 물에 현탁시키고 에테르 100㎖씩으로 3회 추출하였다. 남은 수충을 부탄올 100㎖씩으로 3회 추출한 후에 부탄올 분획을 농축시키고, 수득된 농축물을 메탄올에 용해시켜 HPLC(컬럼: LiChro- sorb NH₂, 이동상: CH₃CN/H₂O/i-PrOH=80/5/15→80/20/15, 검출기: ELSD(Evaporative light scattering detector))로 분석하였다. 측정된 결과는 다음 표 1에 기재된 바와 같다.Four 40 ml stainless steel vessels were added with 5 g of white ginseng and 5 ml of water, respectively, and then sealed and heated at 110 ° C. for 2 hours, 120 ° C. for 2 hours and 3 hours, and 130 ° C. for 2 hours. 5 g of each of the processed ginseng and the commercially produced white ginseng and red ginseng were taken, extracted three times with 100 ml of methanol, concentrated, suspended in water, and extracted three times with 100 ml of ether. The remaining larvae were extracted three times with 100 ml of butanol, and then the butanol fraction was concentrated. The obtained concentrate was dissolved in methanol, and HPLC (column: LiChrosorb NH2, mobile phase: CH₃CN / H₂O / i-PrOH = 80/5/15) was extracted. → 80/20/15, detector: analyzed by ELSD (Evaporative light scattering detector). The measured results are as described in Table 1 below.

Figure pat00001
Figure pat00001

상기 표 1에 기재된 결과로부터 알 수 있는 바와 같이, 본 발명에 따라 가열처리하여 수득한 가공인삼은 수삼, 백삼 및 홍삼 등에는 거의 또는 전혀 존재하지 않는 인삼 사포닌인 Rg3 및 Rg5 성분의 함량이 현저히 증가하여 우수한 약효를 나타낸다.As can be seen from the results shown in Table 1, the processed ginseng obtained by heat treatment according to the present invention has a significant increase in the content of Rg3 and Rg5 components, which are ginseng saponins, which are hardly or never present in fresh ginseng, white ginseng, and red ginseng. It shows excellent efficacy.

상기한 바와 같은 결과에 따라 인삼에 대한 가열온도의 변화에 따른 사포닌 성분, 특히 진세노사이드 Rg3 및 Rg5의 함량 변화를 더욱 구체적으로 확인하기 위하여 가열을 100℃, 110℃, 120℃, 130℃, 150℃, 160℃, 180℃ 및 200℃에서 2시간씩 행하여 얻어진 인삼들의 Rg3 및 Rg5 함량을 측정하여 가열처리하지 않은 인삼(수삼)에서의 함량과 비교하여 보았다. 그 결과는 다음 표 2에 기재한 바와 같다.According to the results as described above, in order to more specifically confirm the change in the content of saponin components, in particular ginsenosides Rg3 and Rg5 according to the change in the heating temperature for ginseng, heating is 100 ℃, 110 ℃, 120 ℃, 130 ℃, Rg3 and Rg5 contents of ginseng obtained by 2 hours at 150 ° C., 160 ° C., 180 ° C. and 200 ° C. were measured and compared with those in untreated ginseng (water ginseng). The results are shown in Table 2 below.

Figure pat00002
Figure pat00002

상기에서 보는 바와 같이 본 발명에서와 같이 120 내지 180℃에서 가열처리된 가공인삼의 경우에 Rg3 및 Rg5와 같은 진세노사이드의 함량이 비처리 수삼이나 홍삼(100℃ 가열)의 경우에 비해 현저히 증가하였음을 알 수 있다. 실험에 사용한 선삼 추출물의 (Rg3 + Rg5 + Rk1)/(Rb1 + Rb2 + Rc + Rd)= 6.1 이었다.
As seen above, the content of ginsenosides such as Rg3 and Rg5 is significantly increased in the case of processed ginseng heated at 120 to 180 ° C as in the present invention, compared to the case of untreated ginseng or red ginseng (100 ° C heating). It can be seen that. (Rg3 + Rg5 + Rk1) / (Rb1 + Rb2 + Rc + Rd) = 6.1 of the ginseng extract used in the experiment.

참고예Reference Example 1. 세포 1. Cell

실험에 사용된 인간 피부 각질세포주인 HaCaT keratinocyte는 Dr. Fusenig(German Cancer Research Center, DKFZ, Heidelberg, Germany)로부터 분양 받아 사용하였다.
HaCaT keratinocyte, a human skin keratinocyte line used in the experiment, It was used for sale from Fusenig (German Cancer Research Center, DKFZ, Heidelberg, Germany).

참고예 2. 통계처리Reference Example 2. Statistics Processing

각 결과에 대한 유의성 검증은 student's t-test를 이용하였다. p<0.05 인 경우 유의성이 있다고 판정하였다.
Student's t-test was used to test the significance of each result. It was determined that p <0.05 was significant.

실험예 1. 피부 각질세포의 활성에 미치는 영향Experimental Example 1. Effect on skin keratinocyte activity

1-1. 1-1. HaCaTHaCaT 세포 배양 Cell culture

인간 피부 각질세포주인 HaCaT keratinocyte는 Dr. Fusenig(German Cancer Research Center, DKFZ, Heidelberg, Germany)로부터 분양 받아 사용하였다. 세포는 DMEM(Dulbecco's Modified Eagle Medium, Gibco BRL Co. USA)에 10% FBS(GIBCO 사14-501F), 10% penicillin-streptomycin(100 unit/㎖, 100 ug/㎖)이 첨가된 배지로 CO2 incubator(SANYO, JAPAN)로 37℃, 5% CO2, 95% air 조건하에서 배양하였다. 세포 분주를 위해서는 0.25% trypsin-EDTA(GIBCO사 25200)를 사용하였으며, 96 웰(well), 24 well에서는 1x105/well, 6 well에서는 1x106/ml의 세포를 가하여 하룻밤 배양한 후에 실험에 사용하였다.
HaCaT keratinocyte, a human dermal keratinocyte line, It was used for sale from Fusenig (German Cancer Research Center, DKFZ, Heidelberg, Germany). Cells DMEM (Dulbecco's Modified Eagle Medium, Gibco BRL Co. USA) 10% FBS (GIBCO Inc. 14-501F), 10% penicillin-streptomycin (100 unit / ㎖, 100 ug / ㎖) CO 2 in a culture medium is added to the Incubator (SANYO, JAPAN) was incubated under 37 ℃, 5% CO 2 , 95% air conditions. For cell division, 0.25% trypsin-EDTA (GIBCO's 25200) was used, followed by incubating overnight with 96 wells, 1x10 5 / well in 24 wells, and 1x10 6 / ml in 6 wells. It was.

1-2. 자외선 조사 및 약물 처리1-2. UV irradiation and drug treatment

자외선 조사는 UVATEC (Sherman Oaks, CA, USA) 조사기를 이용하였으며, UVB lamp를 사용하여 290-320 nm 파장을 가지는 자외선을 조사하였다. 광량은 IL1700 radiometer (International Light Inc., MA, USA)를 사용하여 측정하였다. 자외선을 조사하기 전에 1시간 동안 약물을 농도별(2, 10, 50㎍/㎖)로 가하여 미리 배양하였다. 자외선을 조사하기 위하여 DMEM 배지(WelGENE LM001-05)를 제거한 다음, PBS(welGENE LB001-02)로 2번 씻어낸 후 UVB 파장의 자외선을 30 mJ/cm2 이 되도록 조사하였다. 자외선을 조사한 다음 PBS로 한번 씻어낸 후, 약물이 농도별로 함유된 새로운 DMEM 배지를 넣고 일정 시간동안 배양한 후 실험에 사용하였다.
UV irradiation was performed using a UVATEC (Sherman Oaks, CA, USA) irradiator, and UVB lamp was irradiated with UV light having a wavelength of 290-320 nm. Light quantity was measured using an IL1700 radiometer (International Light Inc., MA, USA). The drug was incubated in advance by adding concentrations (2, 10, 50 µg / ml) for 1 hour before UV irradiation. In order to irradiate ultraviolet rays, DMEM medium (WelGENE LM001-05) was removed, washed twice with PBS (welGENE LB001-02), and then irradiated with UV rays having a UVB wavelength of 30 mJ / cm 2 . After irradiating with UV light, and then washed once with PBS, a new DMEM medium containing the drug by concentration was added and cultured for a predetermined time, and then used for the experiment.

1-3. 니트라이트(1-3. Nitrite ( NitriteNitrite ) ) 생성능Generation 측정 Measure

UV에 의한 피부 각질 세포의 산화적 스트레스를 측정하기 위하여, HaCaT 세포에 UV를 조사한 후 생성되는 니트라이트 (nitrite) 양을 측정하였다. In order to measure the oxidative stress of the skin keratinocytes by UV, the amount of nitrite generated after UV irradiation to HaCaT cells was measured.

하기 실험예 1-4 에 기술한 LDL 측정법과 동일한 과정으로 배양한 다음, 실험군에서 배지 상층액을 취하였다. NaNO2 용액의 연속적인 희석액을 만들어 최종농도가 0.05 μM가 되도록 조절하였다. 먼저 세포배양액과 NaNO2 희석액에 동량의 그리스 시약 용액 (Griess reagent solution; Sigma사 G4410)을 넣고, 15분간 상온에 방치한 다음에 540 nm에서 흡광도를 측정하였다.After incubation in the same manner as the LDL method described in Experimental Example 1-4 below, the culture supernatant was taken from the experimental group. Serial dilutions of the NaNO 2 solution were made and adjusted to a final concentration of 0.05 μM. First, an equal amount of grease reagent solution (Griess reagent G4410) was added to the cell culture solution and the NaNO 2 dilution solution, and the absorbance was measured at 540 nm after being allowed to stand at room temperature for 15 minutes.

실험 결과, 도 1에 나타난 바와 같이, UV 조사시에 세포에서 생성되는 니트라이트 량이 증가하였다. 또한, SG을 처리한 경우, UV로 조사한 대조군에 비해 니트라이트 생성을 억제하여, UV에 의한 산화적 스트레스를 억제하는 작용을 나타내었다.
As a result, as shown in Figure 1, the amount of nitrite produced in the cell at the time of UV irradiation increased. In addition, when SG was treated, the production of nitrite was suppressed compared to the UV-irradiated control group, thereby suppressing oxidative stress caused by UV.

1-4. 1-4. LDHLDH 유리능Viable 측정 Measure

세포를 96 웰 플레이트를 이용하여 24시간 동안 미리 배양한 후, 1 시간 동안 약물을 함유한 배지로 전처리하였다. 세포는 well당 1x104 개씩 넣었다. 배양액을 제거한 다음에 각 well에 50 ㎕의 PBS (phosphate buffered saline)(WelGENE LB001-02)를 넣은 다음, 세포에 UVB를 30 mJ/cm2 를 조사한 후 PBS를 제거하고 웰 (well)당 약물이 포함된 200 ㎕의 DMEM 배지를 첨가하였다. 24시간이 경과한 다음 배양액을 취하여 세포 손상의 지표로 LDH (lactate dehydrogenase) 활성을 측정하였다. LDH 활성은 시그마(Sigma)사의 LDH kit(Sigma S 500)을 이용하여 정량하였으며, ELISA Reader(Molecular Device Emax)를 이용하여 흡광도를 측정하였다.Cells were preincubated for 24 hours using 96 well plates and then pretreated with media containing the drug for 1 hour. Cells were added 1 × 10 4 per well. After removing the culture medium, 50 μl of PBS (phosphate buffered saline) (WelGENE LB001-02) was added to each well, and after 30 mJ / cm 2 of UVB was irradiated to the cells, the PBS was removed and the drug per well was 200 μl of DMEM medium included was added. After 24 hours, the culture medium was taken to measure lactate dehydrogenase (LDH) activity as an indicator of cell damage. LDH activity was quantified using Sigma's LDH kit (Sigma S 500), and absorbance was measured using an ELISA Reader (Molecular Device Emax).

실험 결과, 도 2에 나타난 바와 같이, UV 조사시에 세포로부터 LDH 의 유리가 증가하였다. 또한, 선삼(SG)을 처리한 경우, UV로 조사한 대조군에 비해 LDH의 유리를 억제하여, UV에 의한 진피 세포 상해를 억제하는 작용을 나타내었다.As a result, as shown in Figure 2, the release of LDH from the cells during the UV irradiation increased. In addition, when treated with ginseng (SG), the release of LDH was suppressed compared to the control group irradiated with UV, showing the effect of inhibiting dermal cell injury by UV.


실험예Experimental Example 2. 유전자 발현에 대한 영향 2. Impact on Gene Expression

상기 실시예 1의 선삼 추출물의 MMP-1, Procollagen, c-fos, c-jun, iNOS 유전자 발현에 대한 영향을 알아보기 위해 하기와 같이 실험을 수행하였다.In order to determine the effect on the expression of MMP-1, Procollagen, c-fos, c-jun, iNOS gene of the ginseng extract of Example 1 was performed as follows.

2-1. 총 2-1. gun RNARNA 분리 detach

실험예 1-1에 개시된 내용으로 배양한 HaCaT 세포에 1 ml TRIzol reagent (Invitrogen, Cat.No. 15596018)를 처리하여 총 RNA를 분리하였다. 분리한 RNA 용액에 200㎕의 클로로포름 (Sigma-Aldrich, Cat.No. 288306) : isoamylalcohol (Sigma-Aldrich, Cat.No. 320021) (24:1)을 넣고 강하게 섞은 후에 14000rpm으로 원심 분리하여 상층액 500ul를 분리하였다. 0.5 ml 이소프로필 알콜을 여기에 가하여 영하 20℃에서 하루밤 RNA를 침전시킨 후에 1400rpm으로 20분간 원심 분리하였다. 상등액을 버린 후, 70% 에탄올 (Sigma-Aldrich, Cat.No. 459844)로 세척하고 자연 건조시켰다. RNAase 제거수(RNase-free Water, Sigma-Aldrich, Cat.No. 95289) 에서 RNA를 녹인 후에 RNase-free DNase (Promega, Cat.No. M6101) 를 첨가하고 -70℃에서 저장하였다.
HaCaT cells cultured in the manner described in Experiment 1-1 were treated with 1 ml TRIzol reagent (Invitrogen, Cat. No. 15596018) to isolate total RNA. 200 μl of chloroform (Sigma-Aldrich, Cat.No. 288306): isoamylalcohol (Sigma-Aldrich, Cat.No. 320021) (24: 1) was added to the isolated RNA solution, followed by vigorous mixing and centrifugation at 14000 rpm. 500ul was separated. 0.5 ml isopropyl alcohol was added thereto to precipitate RNA overnight at minus 20 ° C., followed by centrifugation at 1400 rpm for 20 minutes. The supernatant was discarded, washed with 70% ethanol (Sigma-Aldrich, Cat. No. 459844) and dried naturally. After RNA was dissolved in RNAase removal water (RNase-free Water, Sigma-Aldrich, Cat. No. 95289), RNase-free DNase (Promega, Cat.No. M6101) was added and stored at -70 ° C.

2-2. 2-2. cDNAcDNA 제조 Produce

대조군 및 시험군에서 각각 분리한 total RNA 액 1 ul에 (1 ug RNA 함유)에 oligo dT (Promega, Cat. No. C1101) (농도 100pmol) 1 ㎕, RNAase 제거수 (Promega, Cat.No. M6101) 3 ul을 넣은 후, 조심스럽게 혼합한 다음, 65oC에서 10분간 배양하였다. primer가 아닐링(annealing) 하도록 4oC 에서 약 5분간 방치한 다음, 역전사 완충액(Reverse transcriptase buffer), dNTP (Promega, Cat.No. U1515) (각 2.5mM), RNase inhibitor (Promega, Cat.No. N2611), DTT (100nM), 및 역전사효소 (Reverse transcriptase; M-MLV 200U/ul) (Promega, Cat.No. M5301)을 첨가한 후, 아주 조심스럽게 혼합하였다. 이 후, 42oC에서 90분간 배양한 후, 95℃에서 5분간 처리한 후에 사용하였다.
1 μl of oligo dT (Promega, Cat.No. C1101) (concentration 100 pmol) in 1 ul of total RNA solution (containing 1 ug RNA) isolated from the control and test groups, and RNAase removal water (Promega, Cat.No. M6101). ) 3 ul was added, mixed carefully, and incubated at 65 o C for 10 minutes. Leave for 5 minutes at 4 o C to anneal the primers, then reverse transcriptase buffer, dNTP (Promega, Cat.No. U1515) (2.5 mM each), RNase inhibitor (Promega, Cat. No. N2611), DTT (100 nM), and Reverse transcriptase (M-MLV 200 U / ul) (Promega, Cat. No. M5301) were added and then mixed very carefully. Thereafter, the mixture was incubated at 42 ° C. for 90 minutes, and then used after treatment at 95 ° C. for 5 minutes.

2-3 2-3 RTRT -- PCRPCR

Oligo (dT) primer (Promega, Cat. No. C1101), 반응 완충액 (reaction buffer; 50 mM Tris-HCl, 75 mM KCl, 3 mM MgCl2, 10 mM DTT, pH 8.3) (Promega, Cat.No. M1705), 1 mM dNTP (Promega, Cat.No. U1515) 및 200 단위(unit) M-MLV-RT (Moloney murine leukemia virus reverse transcriptase) (Promega, Cat. No. M1705)를 분리한 RNA에 처리하여 역전사를 수행함으로써 cDNA를 합성하였다. PCR은 total volume 25 ㎕에 10X PCR buffer, 0.2 mM dNTPs, 2 pmole의 sense 및 anti-sense primer를 넣은 혼합액에 cDNA와 1.25 unit의 Taq polymerase (Promega, Cat.No. M8295)을 넣어 PCR을 시행하였다. 사용된 primer는 (주)바이오니아(한국)에서 주문 생산하여 사용하였다.Oligo (dT) primer (Promega, Cat.No. C1101), reaction buffer; 50 mM Tris-HCl, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT, pH 8.3) (Promega, Cat.No. M1705), 1 mM dNTP (Promega, Cat.No. U1515), and 200 units of M-MLV-RT (Moloney murine leukemia virus reverse transcriptase) (Promega, Cat.No. M1705) were treated to RNA isolated. CDNA was synthesized by performing reverse transcription. PCR was performed by adding cDNA and 1.25 units of Taq polymerase (Promega, Cat.No. M8295) to a mixture containing 10X PCR buffer, 0.2 mM dNTPs, 2 pmole sense, and anti-sense primer in 25 μl total volume. . The primers used were made to order at Bioneer Korea.

COX-2의 sense primer는 “TTC AAA TGA GAT TGT GGG AAA AT”, antisense는 “AGA TCA TCT CTG CCT GAG TAT CTT” 을 사용하였으며, iNOS의 sense primer는 “CGG TGC TGT ATT TCC TTA CGA GGC GAA GAA GG”, antisense는 “GGT GCT GTC TGT TAG GAG GTC CAA GTA AAG GGC” 를 사용하였다. TNFα의 sense primer는 “TGC ACC ACA GTT TAA ACC CA” 이었으며, antisense는 “GAC TCC TTC AGG TGC TCA GG” 이었다. NF-κB2의 sense primer는 “TCC ACC TTT AGG TTG CCC TG”, antisense는 “TCT GCT CTC GTC ATG TCA CC” 를 사용하였으며, c-Jun의 sense primer는 “GGA TCA AGG CGG AGA GGA AG”, antisense는 “GCG TTA GCA TGA GTT GGC AC”을 사용하였으며, c-Fos의 sense primer는 “GGA GAA TCC GAA GGA AAG G”, antisense는 “GCT TGG GCT CAG GGT CAT TG”를 사용하였다. Bcl-2의 sense primer는 “ACT CTG CTC AGT TTC GCC CT”, antisense는 “TTG TGG CTC AGA TAG GCA C” 를 사용하였으며, Bcl-xL의 sense primer는 “ATG TCT CAG AGC AAC CGG”, antisense는 “TCT TTC CGA CTG AAG AGT G” 를 사용하였다.The sense primer of COX-2 was “TTC AAA TGA GAT TGT GGG AAA AT” and the antisense was “AGA TCA TCT CTG CCT GAG TAT CTT”, and the sense primer of iNOS was “CGG TGC TGT ATT TCC TTA CGA GGC GAA GAA GG ”and antisense used“ GGT GCT GTC TGT TAG GAG GTC CAA GTA AAG GGC ”. The sense primer of TNFα was “TGC ACC ACA GTT TAA ACC CA” and the antisense was “GAC TCC TTC AGG TGC TCA GG”. NF-κB2 sense primers were used as “TCC ACC TTT AGG TTG CCC TG” and antisense was used as “TCT GCT CTC GTC ATG TCA CC” and c-Jun sense primers were “GGA TCA AGG CGG AGA GGA AG” and antisense The GCG TTA GCA TGA GTT GGC AC was used, the sense primer of c-Fos was used as GGA GAA TCC GAA GGA AAG G, and the antisense was GCT TGG GCT CAG GGT CAT TG. The sense primer of Bcl-2 is “ACT CTG CTC AGT TTC GCC CT” and the antisense is “TTG TGG CTC AGA TAG GCA C”. The sense primer of Bcl-xL is “ATG TCT CAG AGC AAC CGG” and antisense is “TCT TTC CGA CTG AAG AGT G” was used.

Control로는 GAPDH를 사용하였으며 sense primer는 “CAGC CTC GTC CCG TAG ACA AA”이었으며, antisense는 “CAC GAC ATA CTC AGC ACC GGC”이었다.GAPDH was used as the control and sense primer was “CAGC CTC GTC CCG TAG ACA AA” and antisense was “CAC GAC ATA CTC AGC ACC GGC”.

PCR 조건은 94℃ 4분, 30 cycles의 [94℃ (20초), 54℃ (20초), 72℃ (30초)], 72℃ 10분이었다(Perkin Elmer, USA) 증폭된 PCR 산물을 2% 아가로스 겔 (agarose gel)에 전기 영동하였다. 전기영동 결과에서 나온 밴드(band)를 밀도 (density) 분석 프로그램인 Gel-Pro analyzer 3.1 (Media Cybernetics. USA)을 이용하여 구했다.  PCR conditions were 94 ° C. 4 min, 30 cycles [94 ° C. (20 sec), 54 ° C. (20 sec), 72 ° C. (30 sec), 72 ° C. 10 min (Perkin Elmer, USA). Electrophoresis was performed on 2% agarose gel. Bands from the electrophoresis results were obtained using a density analysis program, Gel-Pro analyzer 3.1 (Media Cybernetics.USA).

2-4. 2-4. RealReal timetime RTRT -- PCRPCR

각각의 optical tube (MicroAmp® Optical 96-Well Reaction Plate with Barcode and Optical Adhesive Films, Applied Biosystems, Cat.No. 4314320)에 3배의 SybrGreen Mix 2.5 ㎕ (Sigma-Aldrich, Cat.No. S9430), 위에서 합성한 cDNA 1 ㎕, 10 pmol/㎕ primer pair mix 1 ㎕, 각각 2.5mM의 dNTP 2ul, 10xTag polymerase buffer 2.5ul, Tag Polymerase 0.3ul 및 14.7 ㎕ H2O를 넣고, 95oC 5 min 1 cycle, 95oC 30sec, 45oC 30sec, 72oC 60sec 40 cycles, 및 95oC 20 min 1 cycle로 증폭시켰다. PCR을 마친 후에 튜브를 꺼내고, 반응액 5ul를 사용하여 3% 아가로스 겔에서 PCR 특이성 (specificity)를 측정하고, ABI PRISM® 7000 Sequence Detection System (Applied Biosystems, Cat.No. 4349157)를 사용하여 실시간 (real time) PCR 결과를 분석하였다.In each optical tube (MicroAmp® Optical 96-Well Reaction Plate with Barcode and Optical Adhesive Films, Applied Biosystems, Cat.No. 4314320) 2.5 μl of triple SybrGreen Mix (Sigma-Aldrich, Cat.No. S9430), above 1 μl of synthesized cDNA, 1 μl of 10 pmol / μl primer pair mix, 2.5 μl of dNTP 2 μl, 10 × Tag polymerase buffer 2.5 μl, Tag polymerase 0.3 μl and 14.7 μl H 2 O, respectively, 95 o C 5 min 1 cycle, Amplification was performed at 95 ° C 30sec, 45 ° C 30sec, 72 ° C 60sec 40 cycles, and 95 ° C 20 min 1 cycle. After PCR, remove the tube, measure PCR specificity on 3% agarose gel using 5ul of reaction solution, and use the ABI PRISM® 7000 Sequence Detection System (Applied Biosystems, Cat.No. 4349157) in real time. (real time) PCR results were analyzed.

실험 결과, 도 3에 나타난 바와 같이, UV 조사시에 세포에서 생성되는 COX-2의 mRNA의 생성이 증가하였다. 또한, SG을 처리한 경우, UV로 조사한 대조군에 비해 COX-2 유전자 발현을 억제하여, UV에 의한 PGE2 생성을 억제하는 것으로 나타났다.As a result, as shown in Figure 3, the production of COX-2 mRNA produced in the cell during UV irradiation increased. In addition, when SG was treated, COX-2 gene expression was suppressed compared to UV irradiated control, and it was shown to inhibit PGE 2 production by UV.

TNFα는 도 4에 나타난 바와 같이, UV 조사시에 세포에서 생성되는 TNFα의 mRNA의 생성이 증가하였다. 또한, SG을 처리한 경우, UV로 조사한 대조군에서 증가한 TNFα 유전자 발현을 감소시켜, UV에 의한 fibiroblast 작용을 간접적으로 억제할 수 있을 것으로 나타났다.As shown in FIG. 4, TNFα increased the production of mRNA of TNFα produced in cells upon UV irradiation. In addition, SG treatment was found to be able to indirectly inhibit the fibiroblast action by UV by reducing the increased TNFα gene expression in the UV irradiation control.

c-jun은 도 5에 나타난 바와 같이, UV 조사시에 세포에서 생성되는 c-jun의 mRNA의 생성이 증가하였다. 또한, SG을 처리한 경우, UV로 조사한 대조군에서 증가한 c-jun 유전자 발현을 감소시켜, UV에 의한 섬유아세포 (fibroblast) 작용을 간접적으로 억제할 수 있을 것으로 나타났다.As shown in FIG. 5, c-jun increased the production of c-jun mRNA generated in cells upon UV irradiation. In addition, SG treatment was found to be able to indirectly inhibit the fibroblast action by UV by reducing the increased c-jun gene expression in the UV irradiation control.

c-fos는 도 6에 나타난 바와 같이, UV 조사시에 세포에서 생성되는 c-fos의 mRNA의 생성이 증가하였다. 또한, SG을 처리한 경우, UV로 조사한 대조군에서 증가한 c-fos 유전자 발현을 감소시켜, UV에 의한 섬유아세포작용을 억제할 수 있을 것으로 나타났다.As shown in Figure 6, c-fos increased the production of c-fos mRNA produced in the cell upon UV irradiation. In addition, SG treatment was found to reduce the increased c-fos gene expression in the UV irradiated control, thereby inhibiting fibroblast action by UV.

또한, iNOS는 도 7에 나타난 바와 같이, UV 조사시에 세포에서 생성되는 iNOS의 mRNA의 생성이 증가하였다. 또한, SG을 처리한 경우, UV로 조사한 대조군에서 증가한 iNOS 유전자 발현을 감소시켜, UV에 의한 섬유아세포 작용을 억제할 수 있을 것으로 나타났다.In addition, iNOS increased the production of mRNA of iNOS produced in cells upon UV irradiation, as shown in FIG. 7. In addition, SG treatment was shown to reduce the iNOS gene expression increased in the UV irradiated control, inhibiting the fibroblast action by UV.

따라서 상기 선삼 추출물은 UV에 의한 피부 각질세포의 상해를 억제하였으며, 이는 UV에 의해서 증가하는 세포사멸 (apoptosis) 관련 인자 및 조절인자 발현을 조절하여 피부손상 억제에 탁월한 효과가 있음을 확인할 수 있었다.
Therefore, the ginseng extract inhibited skin keratinocyte injury by UV, which was found to have an excellent effect on inhibiting skin damage by controlling the expression of apoptosis-related factors and regulators increased by UV.

재조합 단백질Recombinant protein 프라이머 서열 (Primer sequence)Primer sequence COX-2COX-2 센스: 서열번호1Sense: SEQ ID NO: 1 5'-TTC AAA TGA GAT TGT GGG AAA AT-35'-TTC AAA TGA GAT TGT GGG AAA AT-3 안티센스: 서열번호2Antisense: SEQ ID NO: 2 5'-AGA TCA TCT CTG CCT GAG TAT CTT-3'5'-AGA TCA TCT CTG CCT GAG TAT CTT-3 ' iNOSiNOS 센스: 서열번호3Sense: SEQ ID NO: 3 5'-CGG TGC TGT ATT TCC TTA CGA GGC GAA GAA GG-3'5'-CGG TGC TGT ATT TCC TTA CGA GGC GAA GAA GG-3 ' 안티센스: 서열번호4Antisense: SEQ ID NO: 4 5'-GGT GCT GTC TGT TAG GAG GTC CAA GTA AAG GGC-3'5'-GGT GCT GTC TGT TAG GAG GTC CAA GTA AAG GGC-3 ' TNFαTNFα 센스: 서열번호5Sense: SEQ ID NO: 5 5'-TGC ACC ACA GTT TAA ACC CA-3'5'-TGC ACC ACA GTT TAA ACC CA-3 ' 안티센스: 서열번호6Antisense: SEQ ID NO: 6 5'-GAC TCC TTC AGG TGC TCA GG-3'5'-GAC TCC TTC AGG TGC TCA GG-3 ' NF-κB2NF-κB2 센스: 서열번호7Sense: SEQ ID NO: 7 5'-TCC ACC TTT AGG TTG CCC TG-3'5'-TCC ACC TTT AGG TTG CCC TG-3 ' 안티센스: 서열번호8Antisense: SEQ ID NO: 8 5'-TCT GCT CTC GTC ATG TCA CC-3'5'-TCT GCT CTC GTC ATG TCA CC-3 ' c-Junc-Jun 센스: 서열번호9Sense: SEQ ID NO: 9 5'-GGA TCA AGG CGG AGA GGA AG-3'5'-GGA TCA AGG CGG AGA GGA AG-3 ' 안티센스: 서열번호10Antisense: SEQ ID NO: 10 5'-GCG TTA GCA TGA GTT GGC AC-3'5'-GCG TTA GCA TGA GTT GGC AC-3 ' c-Fosc-Fos 센스: 서열번호11Sense: SEQ ID NO: 11 5'-GGA GAA TCC GAA GGA AAG G-3'5'-GGA GAA TCC GAA GGA AAG G-3 ' 안티센스: 서열번호12Antisense: SEQ ID NO: 12 5'-GCT TGG GCT CAG GGT CAT TG-3'5'-GCT TGG GCT CAG GGT CAT TG-3 ' Bcl-2Bcl-2 센스: 서열번호13Sense: SEQ ID NO: 13 5'-ACT CTG CTC AGT TTC GCC CT-3'5'-ACT CTG CTC AGT TTC GCC CT-3 ' 안티센스: 서열번호14Antisense: SEQ ID NO: 14 5'-TTG TGG CTC AGA TAG GCA C-3'5'-TTG TGG CTC AGA TAG GCA C-3 ' Bcl-xLBcl-xL 센스: 서열번호15Sense: SEQ ID NO: 15 5'-ATG TCT CAG AGC AAC CGG-3'5'-ATG TCT CAG AGC AAC CGG-3 ' 안티센스: 서열번호16Antisense: SEQ ID NO: 16 5'-TCT TTC CGA CTG AAG AGT G-3'5'-TCT TTC CGA CTG AAG AGT G-3 ' GAPDHGAPDH 센스: 서열번호17Sense: SEQ ID NO: 17 5'-CAG CCT CGT CCC GTA GAC AAA-3'5'-CAG CCT CGT CCC GTA GAC AAA-3 ' 안티센스: 서열번호18Antisense: SEQ ID NO: 18 5'-CAC GAC ATA CTC AGC ACC GGC-3'5'-CAC GAC ATA CTC AGC ACC GGC-3 '

하기에 상기 조성물의 제제예를 설명하나, 이는 본 발명을 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.
Examples of the formulation of the composition are described below, but are not intended to limit the present invention but to explain in detail only.

제제예Formulation example 1. 친수성 연고제의 제조 1. Preparation of Hydrophilic Ointment

선삼 추출물 9.00%Ginseng Extract 9.00%

백색 바세린 36.00%White Vaseline 36.00%

스테아릴 알콜 31.00%Stearyl Alcohol 31.00%

에텔(또는 메틸)ρ-옥시벤조에이트 미량Trace amounts of ether (or methyl) ρ-oxybenzoate

프로필렌 글리콜 19.00%Propylene Glycol 19.00%

라우릴 황산 나트륨 2.40%Sodium Lauryl Sulfate 2.40%

프로필 ρ-옥시벤조에이트 미량Trace amount of propyl ρ-oxybenzoate

계 100.00%
Total 100.00%

제제예Formulation example 2. 유연화장수( 2. Flexible Cosmetics 스킨skin )의 제조Manufacturing

선삼 추출물 2.00%Ginseng Extract 2.00%

글리세린 5.00%Glycerin 5.00%

트리에탄올아민 0.50%Triethanolamine 0.50%

토코페릴 아세테이트 1.00%Tocopheryl Acetate 1.00%

유동파라핀 5.00%Liquid Paraffin 5.00%

스쿠알란 5.00%Squalane 5.00%

마카다미아너트 오일 15.00%Macadamia Nut Oil 15.00%

폴리솔베이트60 1.00%Polysorbate60 1.00%

솔비탄세스퀴올레이트 1.00%Solbitan Sesquioleate 1.00%

카르복실비닐폴리머 0.20%Carboxyl Vinyl Polymer 0.20%

방부제 미량Preservative traces

향 미량Trace amount

정제수 잔량Purified water level

계 100.00%
Total 100.00%

제제예Formulation example 3.  3. 밀크로션의Milk croissant 제조 Produce

선삼 추출물 5.00%Ginseng Extract 5.00%

1,3-부틸렌글리콜 4.00%1,3-butylene glycol 4.00%

글리세린 3.00%Glycerin 3.00%

올레일알코올 0.05%Oleyl Alcohol 0.05%

폴리솔베이트20 1.00%Polysorbate20 1.00%

방부제 미량Preservative traces

향 미량Trace amount

정제수 잔량Purified water level

계 100.00%
Total 100.00%

제제예Formulation example 4. 영양 크림의 제조 4. Manufacturing of Nutritional Cream

선삼 추출물 2.00%Ginseng Extract 2.00%

글리세린 5.00%Glycerin 5.00%

트리에탄올아민 0.50%Triethanolamine 0.50%

토코페릴 아세테이트 1.00%Tocopheryl Acetate 1.00%

우동파라핀 5.00%Udon paraffin 5.00%

스쿠알란 5.00%Squalane 5.00%

마카다미아너트 오일 15.00%Macadamia Nut Oil 15.00%

폴리솔베이트60 1.00%Polysorbate60 1.00%

솔비탄세스퀴올레이트 1.00%Solbitan Sesquioleate 1.00%

카르복실비닐폴리머 0.20%Carboxyl Vinyl Polymer 0.20%

방부제 미량Preservative traces

향 미량Trace amount

정제수 잔량Purified water level

계 100.00%
Total 100.00%

제제예Formulation example 5.  5. 맛사지Massage 크림의 제조 Manufacture of cream

선삼 추출물 2.00%Ginseng Extract 2.00%

바세린 5.00%Vaseline 5.00%

유동파라핀 30.00%Liquid Paraffin 30.00%

밀납 3.00%Beeswax 3.00%

폴리솔베이트60 1.00%Polysorbate60 1.00%

솔비탄세스퀴올레이트 1.00%Solbitan Sesquioleate 1.00%

1,3-부틸렌글리콜 5.00%1,3-butylene glycol 5.00%

글리세린 5.00%Glycerin 5.00%

방부제 미량Preservative traces

향 미량Trace amount

정제수 잔량Purified water level

계 100.00%Total 100.00%

<110> GINSENG SCIENCE, INC. <120> Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity <130> DIF/2010-04-0002/KH <160> 18 <170> KopatentIn 1.71 <210> 1 <211> 23 <212> PRT <213> Artificial Sequence <220> <223> COX-2 <400> 1 Thr Thr Cys Ala Ala Ala Thr Gly Ala Gly Ala Thr Thr Gly Thr Gly 1 5 10 15 Gly Gly Ala Ala Ala Ala Thr 20 <210> 2 <211> 24 <212> PRT <213> Artificial Sequence <220> <223> COX-2 <400> 2 Ala Gly Ala Thr Cys Ala Thr Cys Thr Cys Thr Gly Cys Cys Thr Gly 1 5 10 15 Ala Gly Thr Ala Thr Cys Thr Thr 20 <210> 3 <211> 32 <212> PRT <213> Artificial Sequence <220> <223> iNOS <400> 3 Cys Gly Gly Thr Gly Cys Thr Gly Thr Ala Thr Thr Thr Cys Cys Thr 1 5 10 15 Thr Ala Cys Gly Ala Gly Gly Cys Gly Ala Ala Gly Ala Ala Gly Gly 20 25 30 <210> 4 <211> 33 <212> PRT <213> Artificial Sequence <220> <223> iNOS <400> 4 Gly Gly Thr Gly Cys Thr Gly Thr Cys Thr Gly Thr Thr Ala Gly Gly 1 5 10 15 Ala Gly Gly Thr Cys Cys Ala Ala Gly Thr Ala Ala Ala Gly Gly Gly 20 25 30 Cys <210> 5 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> TNFalpha <400> 5 Thr Gly Cys Ala Cys Cys Ala Cys Ala Gly Thr Thr Thr Ala Ala Ala 1 5 10 15 Cys Cys Cys Ala 20 <210> 6 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> TNFalpha <400> 6 Gly Ala Cys Thr Cys Cys Thr Thr Cys Ala Gly Gly Thr Gly Cys Thr 1 5 10 15 Cys Ala Gly Gly 20 <210> 7 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> NF-kB2 <400> 7 Thr Cys Cys Ala Cys Cys Thr Thr Thr Ala Gly Gly Thr Thr Gly Cys 1 5 10 15 Cys Cys Thr Gly 20 <210> 8 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> NF-kB2 <400> 8 Thr Cys Thr Gly Cys Thr Cys Thr Cys Gly Thr Cys Ala Thr Gly Thr 1 5 10 15 Cys Ala Cys Cys 20 <210> 9 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> c-Jun <400> 9 Gly Gly Ala Thr Cys Ala Ala Gly Gly Cys Gly Gly Ala Gly Ala Gly 1 5 10 15 Gly Ala Ala Gly 20 <210> 10 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> c-Jun <400> 10 Gly Cys Gly Thr Thr Ala Gly Cys Ala Thr Gly Ala Gly Thr Thr Gly 1 5 10 15 Gly Cys Ala Cys 20 <210> 11 <211> 19 <212> PRT <213> Artificial Sequence <220> <223> c-Fos <400> 11 Gly Gly Ala Gly Ala Ala Thr Cys Cys Gly Ala Ala Gly Gly Ala Ala 1 5 10 15 Ala Gly Gly <210> 12 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> c-Fos <400> 12 Gly Cys Thr Thr Gly Gly Gly Cys Thr Cys Ala Gly Gly Gly Thr Cys 1 5 10 15 Ala Thr Thr Gly 20 <210> 13 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> Bcl-2 <400> 13 Ala Cys Thr Cys Thr Gly Cys Thr Cys Ala Gly Thr Thr Thr Cys Gly 1 5 10 15 Cys Cys Cys Thr 20 <210> 14 <211> 19 <212> PRT <213> Artificial Sequence <220> <223> Bcl-2 <400> 14 Thr Thr Gly Thr Gly Gly Cys Thr Cys Ala Gly Ala Thr Ala Gly Gly 1 5 10 15 Cys Ala Cys <210> 15 <211> 18 <212> PRT <213> Artificial Sequence <220> <223> Bcl-xL <400> 15 Ala Thr Gly Thr Cys Thr Cys Ala Gly Ala Gly Cys Ala Ala Cys Cys 1 5 10 15 Gly Gly <210> 16 <211> 19 <212> PRT <213> Artificial Sequence <220> <223> Bcl-xL <400> 16 Thr Cys Thr Thr Thr Cys Cys Gly Ala Cys Thr Gly Ala Ala Gly Ala 1 5 10 15 Gly Thr Gly <210> 17 <211> 21 <212> PRT <213> Artificial Sequence <220> <223> GAPDH <400> 17 Cys Ala Gly Cys Cys Thr Cys Gly Thr Cys Cys Cys Gly Thr Ala Gly 1 5 10 15 Ala Cys Ala Ala Ala 20 <210> 18 <211> 21 <212> PRT <213> Artificial Sequence <220> <223> GAPDH <400> 18 Cys Ala Cys Gly Ala Cys Ala Thr Ala Cys Thr Cys Ala Gly Cys Ala 1 5 10 15 Cys Cys Gly Gly Cys 20 <110> GINSENG SCIENCE, INC. <120> Cosmetic composition comprising the extract of heat-processed          panax ginseng showing skin anti-aging activity <130> DIF / 2010-04-0002 / KH <160> 18 <170> KopatentIn 1.71 <210> 1 <211> 23 <212> PRT <213> Artificial Sequence <220> <223> COX-2 <400> 1 Thr Thr Cys Ala Ala Ala Thr Gly Ala Gly Ala Thr Thr Gly Thr Gly   1 5 10 15 Gly Gly Ala Ala Ala Ala Thr              20 <210> 2 <211> 24 <212> PRT <213> Artificial Sequence <220> <223> COX-2 <400> 2 Ala Gly Ala Thr Cys Ala Thr Cys Thr Cys Thr Gly Cys Cys Thr Gly   1 5 10 15 Ala Gly Thr Ala Thr Cys Thr Thr              20 <210> 3 <211> 32 <212> PRT <213> Artificial Sequence <220> <223> iNOS <400> 3 Cys Gly Gly Thr Gly Cys Thr Gly Thr Ala Thr Thr Thr Cys Cys Thr   1 5 10 15 Thr Ala Cys Gly Ala Gly Gly Cys Gly Ala Ala Gly Ala Ala Gly Gly              20 25 30 <210> 4 <211> 33 <212> PRT <213> Artificial Sequence <220> <223> iNOS <400> 4 Gly Gly Thr Gly Cys Thr Gly Thr Cys Thr Gly Thr Thr Ala Gly Gly   1 5 10 15 Ala Gly Gly Thr Cys Cys Ala Ala Gly Thr Ala Ala Ala Gly Gly Gly              20 25 30 Cys     <210> 5 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> TNFalpha <400> 5 Thr Gly Cys Ala Cys Cys Ala Cys Ala Gly Thr Thr Thr Ala Ala Ala   1 5 10 15 Cys Cys Cys Ala              20 <210> 6 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> TNFalpha <400> 6 Gly Ala Cys Thr Cys Cys Thr Thr Cys Ala Gly Gly Thr Gly Cys Thr   1 5 10 15 Cys Ala Gly Gly              20 <210> 7 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> NF-kB2 <400> 7 Thr Cys Cys Ala Cys Cys Thr Thr Thr Ala Gly Gly Thr Thr Gly Cys   1 5 10 15 Cys Cys Thr Gly              20 <210> 8 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> NF-kB2 <400> 8 Thr Cys Thr Gly Cys Thr Cys Thr Cys Gly Thr Cys Ala Thr Gly Thr   1 5 10 15 Cys Ala Cys Cys              20 <210> 9 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> c-Jun <400> 9 Gly Gly Ala Thr Cys Ala Ala Gly Gly Cys Gly Gly Ala Gly Ala Gly   1 5 10 15 Gly Ala Ala Gly              20 <210> 10 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> c-Jun <400> 10 Gly Cys Gly Thr Thr Ala Gly Cys Ala Thr Gly Ala Gly Thr Thr Gly   1 5 10 15 Gly Cys Ala Cys              20 <210> 11 <211> 19 <212> PRT <213> Artificial Sequence <220> <223> c-Fos <400> 11 Gly Gly Ala Gly Ala Ala Thr Cys Cys Gly Ala Ala Gly Gly Ala Ala   1 5 10 15 Ala Gly Gly             <210> 12 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> c-Fos <400> 12 Gly Cys Thr Thr Gly Gly Gly Cys Thr Cys Ala Gly Gly Gly Thr Cys   1 5 10 15 Ala Thr Thr Gly              20 <210> 13 <211> 20 <212> PRT <213> Artificial Sequence <220> <223> Bcl-2 <400> 13 Ala Cys Thr Cys Thr Gly Cys Thr Cys Ala Gly Thr Thr Thr Cys Gly   1 5 10 15 Cys Cys Cys Thr              20 <210> 14 <211> 19 <212> PRT <213> Artificial Sequence <220> <223> Bcl-2 <400> 14 Thr Thr Gly Thr Gly Gly Cys Thr Cys Ala Gly Ala Thr Ala Gly Gly   1 5 10 15 Cys ala cys             <210> 15 <211> 18 <212> PRT <213> Artificial Sequence <220> <223> Bcl-xL <400> 15 Ala Thr Gly Thr Cys Thr Cys Ala Gly Ala Gly Cys Ala Ala Cys Cys   1 5 10 15 Gly gly         <210> 16 <211> 19 <212> PRT <213> Artificial Sequence <220> <223> Bcl-xL <400> 16 Thr Cys Thr Thr Thr Cys Cys Gly Ala Cys Thr Gly Ala Ala Gly Ala   1 5 10 15 Gly Thr Gly             <210> 17 <211> 21 <212> PRT <213> Artificial Sequence <220> <223> GAPDH <400> 17 Cys Ala Gly Cys Cys Thr Cys Gly Thr Cys Cys Cys Gly Thr Ala Gly   1 5 10 15 Ala Cys Ala Ala Ala              20 <210> 18 <211> 21 <212> PRT <213> Artificial Sequence <220> <223> GAPDH <400> 18 Cys Ala Cys Gly Ala Cys Ala Thr Ala Cys Thr Cys Ala Gly Cys Ala   1 5 10 15 Cys Cys Gly Gly Cys              20

Claims (6)

진세노사이드 Rb1, Rb2, Rc, Rd의 함량의 합보다도 진세노사이드 Rg3, Rg5, Rk1의 함량의 합이 더 높은 가공된 파낙스속 인삼 추출물을 유효성분으로 함유하는 피부 노화 방지용 화장료 조성물.A cosmetic composition for preventing skin aging containing, as an active ingredient, a processed Panax ginseng extract having a higher sum of contents of ginsenosides Rg3, Rg5, and Rk1 than the sum of contents of ginsenosides Rb1, Rb2, Rc, and Rd. 제 1항에 있어서,
상기 가공된 파낙스속 인삼 추출물은 파낙스속 식물을 세절하여 가압멸균기에 넣고 70 ℃ 내지 150 ℃에서, 약 2 내지 30기압 하에서 약 1시간 내지 24시간 동안 가열하여 얻어지는 추출물임을 특징으로 하는 화장료 조성물.
The method of claim 1,
The processed Panax ginseng extract is a cosmetic composition, characterized in that the extract obtained by cutting the panax genus plants into autoclaved sterilizer at 70 ℃ to 150 ℃, heated for about 1 to 24 hours under about 2 to 30 atm.
제 1항에 있어서,
상기 가공된 파낙스속 인삼 추출물은 파낙스속 식물을 세절하여 가압멸균기에 넣고 70 ℃ 내지 150 ℃에서, 약 2 내지 30기압 하에서 약 1시간 내지 24시간 동안 가열한 후, 시료 중량의 약 1배 내지 20배 중량비(w/w)의 물, C1 내지 C4의 저급 알콜 또는 이들의 혼합용매로, 냉침추출, 열수추출, 초음파 추출, 환류냉각추출, 또는 가열추출 법으로 추출한 후, 그 여과물을 여과하고 감압농축 및 건조하는 단계를 포함하는 공정을 통하여 수득되는 인삼 가공 추출물임을 특징으로 하는 화장료 조성물.
The method of claim 1,
The processed Panax ginseng extract is cut into the Panax genus plants and put in a autoclave sterilized at 70 ℃ to 150 ℃, heated for about 1 to 24 hours under about 2 to 30 atm, about 1 to 20 times the weight of the sample After extracting by pear weight ratio (w / w) of water, C 1 to C 4 lower alcohol or a mixed solvent thereof by cold extraction, hot water extraction, ultrasonic extraction, reflux cooling extraction, or heat extraction, the filtrate was extracted. Cosmetic composition, characterized in that the ginseng processed extract obtained through a process comprising the step of filtration and concentrated under reduced pressure.
제 1항에 있어서, 상기 파낙스속 식물은 인삼 (Panax ginseng C.A. Meyer), 화기삼(Panax quinquefolium), 전칠삼 (Panax notoginseng), 죽절삼 (Panax japonicum), 삼엽삼 (Panax trifolium) 또는 히말라야삼 (Panax pseudoginseng)인 화장료 조성물.According to claim 1, wherein the genus Panax ginseng (Panax ginseng CA Meyer), Panax quinquefolium, Panax notoginseng, Panax japonicum, Panax trifolium or Himalaya ginseng (Panax pseudoginseng) Cosmetic composition). 제 1항에 있어서, 상기 추출물은 조성물 총 중량에 대하여 0.001 내지 90 중량%로 함유되는 것을 특징으로 하는 화장료 조성물.According to claim 1, wherein the extract is a cosmetic composition, characterized in that contained in 0.001 to 90% by weight relative to the total weight of the composition. 제 1항에 있어서, 상기 조성물은 화장수, 스킨, 로션, 영양로션, 영양크림, 마사지 크림, 에센스, 팩, 클렌징, 세안제, 비누, 트리트먼트, 미용액의 제형으로 구성된 그룹에서 선택된 제형임을 특징으로 하는 화장료 조성물.
The method of claim 1, wherein the composition is a formulation selected from the group consisting of a lotion, skin, lotion, nutrition lotion, nutrition cream, massage cream, essence, pack, cleansing, face wash, soap, treatment, essence Cosmetic composition.
KR1020100051405A 2010-05-31 2010-05-31 Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity KR20110131783A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100051405A KR20110131783A (en) 2010-05-31 2010-05-31 Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100051405A KR20110131783A (en) 2010-05-31 2010-05-31 Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity

Publications (1)

Publication Number Publication Date
KR20110131783A true KR20110131783A (en) 2011-12-07

Family

ID=45500097

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100051405A KR20110131783A (en) 2010-05-31 2010-05-31 Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity

Country Status (1)

Country Link
KR (1) KR20110131783A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101402491B1 (en) * 2012-04-12 2014-06-03 주식회사 한국인삼공사 Composition For Preventing Skin Aging and Improving Skin Wrinkle
CN106420459A (en) * 2016-10-10 2017-02-22 广州今盛美精细化工有限公司 Ginseng water live essence, preparation method thereof and facial mask containing same
CN105434279B (en) * 2015-12-30 2018-06-29 云南人羞花化妆品有限公司 A kind of Radix Notoginseng massage cream and preparation method thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101402491B1 (en) * 2012-04-12 2014-06-03 주식회사 한국인삼공사 Composition For Preventing Skin Aging and Improving Skin Wrinkle
CN105434279B (en) * 2015-12-30 2018-06-29 云南人羞花化妆品有限公司 A kind of Radix Notoginseng massage cream and preparation method thereof
CN106420459A (en) * 2016-10-10 2017-02-22 广州今盛美精细化工有限公司 Ginseng water live essence, preparation method thereof and facial mask containing same

Similar Documents

Publication Publication Date Title
JP5085321B2 (en) Topical skin preparation
KR100828193B1 (en) Composition comprising an extract of nelumbo nucifera gaertner showing skin whitening, anti-aging and anti-wrinkle activity
KR100771397B1 (en) Cosmetic composition comprising an extract of dandelion or luteolin isolated therefrom having anti-oxidant activity and anti-inflammatory activity
WO2001026670A1 (en) Skin-care agents, skin antiaging agents, whitening agents and external skin preparations
JP2004517844A (en) Use of DNA repair enzymes as MMP1 inhibitors
KR102121944B1 (en) Cosmetic composition comprising extract of bud of Nypa fruiticans
KR101086736B1 (en) Composition comprising a crude complex herb extract showing anti-aging and anti-wrinkle activity
KR20210066750A (en) Novel use of milk exosome
KR20090121102A (en) Compositions comprising seaweeds extract for improving and alleviating inflammation and irritation of skin
KR101010744B1 (en) Composition comprising the extract of Rehmannia glutimosa LIBOSCH. having antioxidative effect
KR20090130584A (en) Cosmetic composition comprising an extract of mixed herbs having skin whitening and wrinkle improving activity
KR100773411B1 (en) Crude drug composition showing anti-oxidative, anti-tumor and anti-bacterial activity
KR100805386B1 (en) A composition comprising the fruit extract of platycarya strobilacea having anti-aging activity
KR101263547B1 (en) Cosmetic composition comprising green tea seed coater extract having anti-oxidative or anti-inflammatory activity
KR20110131783A (en) Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-aging activity
KR20110056884A (en) Composition comprising the mixture of map and msm for preventing baldness and improving hair growth
KR20090093363A (en) Cosmetic composition comprising the extract of Polygonum multiflorum showing skin whitening and anti-aging activity
KR20090097483A (en) Composition comprising the mixed extract comprising mylabris sidae fabricius showing reduced toxicity for treating and improving leukoplakia
KR20110131784A (en) Cosmetic composition comprising the extract of heat-processed panax ginseng showing skin anti-wrinkle activity
KR100773406B1 (en) Crude drug composition showing anti-oxidative, anti-tumor and anti-bacterial activity
KR100748851B1 (en) A topical composition comprising extract of ardisia crenata showing anti-inflammatory and anti-irritation activity
JP6375087B2 (en) Cosmetics
KR20110041098A (en) Skin external composition for skin whitening and antiaging containing herbal supercritical extracts
KR100523241B1 (en) Cosmetic composition comprising an extract of Chlorella having anti-inflammatory activity
KR101042690B1 (en) A composition comprising extract of Polystichum ovatopaleaceum var. coraiense H. Christ Sa.Kurata having anti-aging and anti-wrinkle activity

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application